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T cell plays an important role in clearance of viral infections and development of 
memory population for a rapid immune response in the case of secondary infections. T 
cells utilize T cell receptor (TCR) to recognize viral antigens in the form of peptide major 
histocompatibility complex (pMHC) as its ligand. When viral mutations occur, TCR 
recognition is impaired for its ligand and in result, lowers immune cell lytic response. 
Conventionally, TCR binding kinetics to its ligands is linked to TCR binding propensity 
stemming from 3D assays, providing numerical values in relation to its strength. 
However, characterizing the interaction of viral variant peptides to TCR is poorly 
understood and providing a unique perspective in understanding the interaction provides 
potential solutions to vaccine development, especially for chronic viral infections. In this 
study, we characterize Cytomegalovirus (CMV)-specific T cell 2D effective binding 
affinity to both WT and viral variants. Additionally, we characterized to elucidate the 
importance of specific amino acids found on the peptide influences recognition, thereby 
potentially bridging gap to understand the mechanics of how specific recognition motifs 
influence functionality. As T cell gets activated following peptide recognition, multiple 
signaling pathways take place in order to invoke an effective functional output. To invoke 
such a response, T cells first translate from naïve to activated state and then returning to 
homeostasis over the course of an immune response. Although the entire process takes 
several days, how recognition dynamics is influenced in the context of viral clearance and 
how that leads into developing memory population has not been fully elucidated. To 
understand these phenomenon, we primarily evaluated a single transgenic T cell 
 xiv 
population over the course of an acute lymphocytic choriomeningitis virus (LCMV) viral 
infection to characterize and understand the dynamics of the T cell function and 
development that is influenced by organ compartmentalization. Our results highlight an 
important aspect on how TCR propensity is influenced by the microenvironments during 
viral clearance and in the occurrence of viral mutation, how characterizing TCR 










 Cytotoxic T Lymphocytes (CTL) recognition to viral peptides plays a crucial 
component in initiating multiple downstream signaling cascades to effectively eliminate 
viral pathogens found within the host, followed by which establishing a proper adaptive 
immune repertoire to fight off secondary infections. Different organs provide various 
functions to maintain homeostasis for the host and the secondary lymphoid organs (SLO) 
plays an important role in maintaining immune homeostasis stemming from T cell 
development and priming of CTL. Although the immunity of the host combats foreign 
pathogen to its utmost capability, on occasions, viral mutations takes place that leads to 
impaired T cell recognition, where no longer T cells cannot adapt to such mutations. In 
result, viral mutations stemming from selection pressure has the potential to non-effective 
CTL function, thereby contributing to the development of chronic infections. Current 
understanding of how viral mutations influence T cell function is characterized in detail 
with standard affinity measurement and has shown correlation to function, however, 
characterizing the interplay between interaction profile leading to impaired function has 
not been clearly elucidated. Furthermore, existing knowledge of microenvironments 
influencing CTL functions are not well characterized in the context of viral immunity and 
most importantly, how this response shapes up the viral adaptive immune system 
mediated via TCR dynamics and its environment has not been investigated. Therefore, 
the following objectives and specific aims are proposed to investigate the role of viral 
variant epitopes and microenvironmental influence on T cell kinetics utilizing 2D 
biophysical approach to analytically interpret new insights bridging engineering in the 
field of virology and immunology.   
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1.2 Objectives 
The primary objective of this study is to understand and characterize the kinetics 
of TCR and its ligand, pMHC, of both the wild type and mutant variants of the viral 
epitope in the state of infection. In addition, during the course of infection, how antigen 
specific T cells from different compartments regulate CD8+ T cells to its cognate viral 
epitope will also be characterized. 
1.2 Aims and hypotheses 
Aim 1. Characterize the relationship of wild type antigen-specific CD8+ T cell to a 
single antigen epitope and its mutant variants by biophysical assays and functional 
studies from cell line derived from virus-positive subject. 
 This aim will first validate the biophysical and functional characteristics of CMV 
epitope, specifically NLV epitope. This will be done using CD8+ T cell line derived from 
human subject pulsed with the wild type viral peptide. Biophysical parameters of this 
system will be derived by conducting micropipette adhesion frequency and Biomembrane 
Force Probe (BFP) to measure 2D affinity and characterize the effect different amino acid 
with different non-covalent bond observed, respectively. Functional study will be 
conducted by intracellular cytokine staining assay to validate and correlate the 2D 
biophysical results using plate-bound pMHC stimulation. This aim will primarily test the 
hypothesis whether the different mutations of the CMV epitopes will have different 
functional and binding characteristics. Just as various mutations of HCV epitopes have 
direct consequences to the outcome of the disease, we will mimic this scenario with 
CMV NLV epitope. However, this aim looks to understand how each wild type sequence 
and its mutant counterpart of CMV affects the binding kinetics. It is hypothesized that 
mutations at amino acid hot-spots of the antigenic peptide will exhibit low binding 
affinity and significantly impacted lifetime under various forces depicting viral variants 
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utilize to reduce or escape lytic function. Mutations pertaining to comparable or lower 
recognition will exhibit comparable or lower binding affinity and exhibit catch-bond like 
behavior compared to the wild type peptide. The interaction will be assessed between 
mutant variants pMHCs to CD8+ T cells derived from human subject pulsed with wild 
type viral peptide. The result of this will shed light into how T cell response is affected by 
different sequences of various epitopes of CMV and the insights obtained from this study 
could potentially be extrapolated to a more clinically relevant viral disease, such as HCV 
infection. 
Aim 2. Assess the 2D kinetics of antigen specific T cells from circulation (RP) and 
tissue (WP) compartments from spleen of LCMV-infected mice over the course of 
the time and relate to functional role in the path to clear infection and adopting a 
memory repertoire. 
 This aim will test the hypothesis that infection will induce morphologically and 
functionally distinct spleen compartments in influencing CTL binding kinetics and 
function response primarily due to the different compositions at respective compartments. 
A LCMV mouse model will be used for this aim to study following infection leading to 
compartmentalization of antigen-specific T cells and how this reflects on the TCR/pMHC 
binding capability. It is hypothesized that CTLs at sites where LCMV replication is 
favored will exhibit higher 2D affinity than at other sites. More specifically, the 2D 
affinity of the CTL will vary transiently over the course of the viral and establishing 
homeostasis. For 2D kinetics, micropipette adhesion frequency assay will be conducted 
to measure the affinity. BFP will also be used to measure force-lifetime data and 
characterize the differences observed from different compartments. For functional study, 
intracellular cytokine staining assay from respective compartments will be performed and 
analyzed. This aim looks to understand how microenvironment influences T cell kinetics 
and its role in memory development. Various factors are known to negatively impact 
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CTL response and this could potentially mediate CTL binding kinetics and function. 
Using IV injection to tag adoptively transferred antigen-specific transgenic T cells, we 
can separate those from vasculature and from tissue-residence. The result of this will 
provide the dynamics that takes place over the course of the infection and as well, 
propose a mechanism of the regulation of T cell binding kinetics to obtain better 
understanding of how different compartments within SLO influence T cell development. 
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CHAPTER 2 
BACKGROUND AND SIGNIFICANCE 
 
2.1 Background 
2.1.1 Cytotoxic T Lymphocytes  
 Immune response is branched into either innate or adaptive system and CTLs are 
a subset of leukocytes that are part of the adaptive system capable of inducing cytolytic 
activity on cells presenting foreign antigen peptide (p). TCRs expressed on CD8+ T cells 
interacts with pMHC on antigen presenting cells, such as dendritic cells. Each T cell is 
unique in that they are specific in scanning pMHC complexes, which encodes antigens 
derived from pathogen and tumors [11]. The CD8 co-receptor on T cell surface potentiate 
the TCR-pMHC interaction by binding to the a3 domain of the MHC class I molecule, 
inducing a stronger signal [12].  
 Signaling of T cell activity by TCR/pMHC recognition is conducted by a group of 
transmembrane proteins, CD3 molecules, which form a complex with the TCR. 
Cytoplasmic domain of CD8 is associated with lymphocyte-specific protein tyrosine 
kinase (LCK) that phosphorylates immunoreceptor tyrosine-based motifs (ITAMs) found 
on the cytoplasmic segments of CD3. Followed by, recruitment and activation of Zeta-
chain-associated protein kinase 70 (ZAP-70) in the cytosol takes place, which in turn 
phosphorylates linker for activation of T cells (LAT) and src-homology-2-domain-
containing leukocyte protein of 76kDa (SLP-76), which results in signal amplification 
and diversification [12].  
 CTLs react to pathogen to clear infection within the host by priming, massive 
expansion, and differentiation that takes place in lymphoid organs upon interaction with 
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antigen presenting cells (APCs) with the outcome to protect the host with minimal local 
tissue damage [13, 14]. 
2.1.2 Antigen Presenting Cell 
Antigens are toxins or foreign substances that induce immune response by the 
host either by TCR recognition or with antibodies. Antigens are composed of several 
antigenic determinants, known as epitopes, and these epitopes docked on MHC bind to a 
specific TCR. Viral entry into cell is by one of two pathways: (1) virions bind and fuse to 
the cell surface by the forming an interaction between glycoproteins on the virion and its 
respective proteins found on cell surface. (2) Alternatively, virions gain entry into cell by 
receptor-mediated endocytosis. The outcome of either of these pathways ensures  
the viral genome and associated proteins enter the cytoplasm [15-17].  
 Followed by the entry of the virus mediated through the endogenous pathway, 
virus associated proteins are degraded by the proteasome, which results in peptides that 
are shuttled into the endoplasmic reticulum. In the process, the complex pMHC is formed 





Figure 1. The endogenous pathway. The arrows highlighted in red depict the 
endogenous pathway. Intracellular pathogens are degraded by proteasome and the 
resulting peptides are shuttled into the endoplasmic reticulum and are complexed to 
the MHC molecule. The entire complex is then presented at the surface of the cell. 
Adapted and modified from [4]. 
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act upon after forming interaction and initiate functional response mediated by 
recognition and potency of the peptide (Figure 1) [15-17]. 
2.1.3 Viruses 
 As humans carry lifelong, persistent viral infections, human CTLs are thought to 
play an important role in controlling these infections. CTLs recognize viral antigen in the 
form of HLA class I molecules, leading to activation of the CTLs to eliminate target 
infected cell through perforin/granyzme lytic granule secretion or killing mediated by 
Fas/FasL pathway to secrete antiviral cytokines [18]. Humans carry asymptomatic viral 
infection with more than 70% of adults infected with Epstein Barr Virus (EBV) and 80-
90% of adult populations carry CMV [19, 20]. Other viral infection that are severe to the 
host are HCV (~170 million people worldwide) and Human Immunodeficiency Virus 
(HIV; ~33 million people worldwide) that poses challenge to the immune system with 
inhibitor molecules like the effect of programmed death 1 (PD-1) influence TCR 
activation has been observed [21-23]. However, another strategy by which virus evade 
immune function is via mutations that benefits its viral fitness [24]. Additionally, for 
successful replication and infection to other cells for survival, viruses inactivate cellular 
and organismal defense and tegument proteins found in the viruses disrupt antiviral 
immune system that includes, intrinsic, innate, and adaptive immune system [15]. 
2.1.4 Viral Immune Response 
 Chronic infection can severely disrupt the immune response capability of killing 
the target infected cell resulting incompetent of clearing the viral infection [25, 26]. At 
the onset of viral infection, normal viremia replication takes place due to delayed onset of 
CD4+ and CD8+ T-cell response, upon which transient control of viremia and rise in 
transaminases is observed. In chronic cases, some viral variants survive after the peak of 
the immune response and following the contraction of the CD4+ T cell response. Those 
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that survive, a select few based on viral fitness allows viremia to rebounds displaying 
persistent viral infection. At this point, if the immune system is incapable of adapting to 
the viral variants by inducing proper immune response to clear out the secondary viremia, 
a chronic infection is initiated and persisted for the host. Chronic infection in some 
infection is in part result of viruses bearing variant epitope representing a mechanism of 
persistence (Figure 2) [27]. 
 
2.1.5 Viral Variant 
 The cause of TCR variants observed is a result of viral mutations. Typically, viral 
epitope specific TCRs on CTLs recognize highly conserved internal viral proteins. For 
the interest of this study, focus is on peptides associated with MHC class I molecules for 
its interaction with CTLs. While infected cell utilizes the machinery to express viral 
epitope on the cell surface, components of viral proteins from the virion can disrupt the 
presentation of the epitope by taking command of certain machinery and/or impact 
recognition of the TCR by generation of amino acid substitutions. One result of a single 
amino acid alteration can take place at anchoring residues resulting in complete loss of 
© 2005 Nature Publishing Group 
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(IFN-!)23,26,27, but it is also possible that relatively few hepatocytes are
infected in these individuals, which would limit the extent of CTL-
mediated liver damage. 
Chronic infection
As discussed in detail below, HCV-specific CD8+ T cells can survive
for years in the persistently infected liver and thus might at least 
partially control ongoing viral replication and/or contribute to pro-
gressive liver disease. With regard to viral replication, it is noteworthy
that levels of viraemia remain relatively stable over time in subjects
with chronic infections even though they can differ widely between
individuals (Fig. 1). Data regarding the relationship between intra-
hepatic CTLs and viral load have been conflicting28–31, and thus
whether they contribute to control of HCV replication in chronic
hepatitis C or explain the wide variation in viraemia between individ-
uals is not known. Similarly, although virus-specific CTLs are con-
centrated within the liver in chronic infection29,30,32, they have only
inconsistently been correlated with disease severity29,31. Some studies
have documented an association between elevated transaminases and
liver infiltration by CD8+ T cells31,33, but it is possible that only a minor-
ity of the infiltrate is HCV specific34. Intrahepatic pro-inflammatory
cytokine messenger RNA (mRNA) levels have been correlated with
severity of portal inflammation and liver fibrosis35,36. However, it is
unclear whether HCV-specific liver infiltrating lymphocytes are the
major cellular source of pro-inflammatory cytokines, such as IFN-!,
in HCV-associated chronic hepatitis36. Importantly, recruitment of
other inflammatory cell types such as macrophages that can mediate
tissue injury also occurs in chronic hepatitis C36. Thus, studies to weigh
the contribution of both antigen-specific and antigen-independent
mechanisms in chronic hepatocellular injury are needed.
Parsing T-cell responses in resolving and persistent infections
Features that distinguish T-cell responses providing transient versus
permanent viral control are not fully defined. Comparisons have
focused on the number of epitopes targeted by acute-phase T cells,
their frequency in blood and their fate as infections clear or persist.
CD8+ T-cell responses are perhaps the best characterized. Successful
responses generally target multiple major histocompatibility complex
(MHC) class I-restricted epitopes in structural and non-structural
HCV proteins9,24,37,38, and frequencies against individual epitopes often
exceed 3–4% (ref. 37). Interestingly, late expansion of HCV-specific
CD8+ T cells may be accompanied by a further delay in their produc-
tion of IFN-!22,24,37, although the significance of this phenomenon to
infection outcome is uncertain.
Infections that follow a chronic course are usually marked by low
frequencies of CTLs targeting few epitopes28,39–42, although occasion-
ally the strength and breadth of the response can approximate those of
resolving infections43. HCV-specific CTLs are not necessarily deleted
as infections persist and, although difficult to detect in blood, can sur-
vive in the persistently infected liver for years29,30,32,44,45 and in some
cases target a surprisingly broad array of epitopes. For example, intra-
hepatic CTL populations recognizing eight HCV epitopes were con-
sistently recovered from a chimpanzee throughout years of persistent
infection45,46, and CTL clones isolated at diverse timepoints often
retained use of identically recombined T-cell receptor (TCR) " and #
chains47, providing genetic evidence of their remarkable stability
despite ongoing viral replication. These intrahepatic populations are
almost certainly a remnant of a once robust acute phase response.
Strong CD8+ T-cell immunity in acute resolving hepatitis C is
matched by vigorous, sustained CD4+ T-cell proliferation to multiple
recombinant structural and non-structural viral proteins19–21. By con-
trast, HCV antigen-driven proliferation in individuals who develop
persistent infections is usually weak or absent when compared with
spontaneously resolving infections19–22. Nevertheless, transient CD4+
T-cell proliferative responses that are indistinguishable from those in
acute resolving infections have been described21,22, and although pos-
sibly rare do indicate that HCV can evade what appears to be initially
Liver damage is monitored by levels of hepatic enzymes (transam-
inases) released into the serum following hepatocellular injury. Acute
hepatitis C is probably immunopathological because it coincides tem-
porally with expansion of virus-specific CD8+ T cells or cytotoxic T
lymphocytes (CTLs)9,22–24 and their acquisition of an activated pheno-
type25. Curiously, acute infection can sometimes resolve without a
serum transaminase increase. This could reflect non-cytolytic control





















Figure 1 | Schematic representation of the cellular immune response during
acute HCV infection. a, Viraemia (red line) is present early, and although it
usually falls from peak levels, it is never controlled. Persistent infection
ensues, with plasma viral levels that vary widely between individuals. CD4+
and CD8+ T-cell responses (black and green lines, respectively) and rises in
serum transaminase (blue) in this setting remain poorly characterized, and
may be weak or even absent. Progressive shading indicates the high degree of
variability in responses between individuals. b, Viraemia may persist for
many weeks in the absence of a demonstrable cellular immune response. The
delayed onset of CD4+ and CD8+ T-cell responses is associated with transient
control of viraemia and a variable rise in transaminases. However, following
contraction of the CD4+ T-cell response, viraemia rebounds and ultimately
infection persists. Detectable CD8+ T-cell responses may persist despite
chronic viraemia. Shading indicates variability in viral load between
individuals in the chronic phase. c, Although viraemia arises early and T-cell
responses are delayed, the virus becomes undetectable in plasma following
emergence of CD4+ and CD8+ T-cell responses, which are often coincident
with a variable rise in serum transaminases. A rebound in viraemia may occur
before final viral clearance. 
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(IFN-!)23,26,27, but it is also possible that relatively few hepatocytes are
infected in these individuals, which would limit the extent of CTL-
mediated liver damage. 
Chronic infection
As discussed in detail below, HCV-specific CD8+ T cells can survive
for years in the persistently infected liver and thus might at least 
partially control ongoing viral replication and/or contribute to pro-
gressive liver disease. With regard to viral replication, it is noteworthy
that levels of viraemia remain relatively stable over time in subjects
with chronic infections even though they can differ widely between
individuals (Fig. 1). Data regarding the relationship between intra-
hepatic CTLs and viral load have been conflicting28–31, and thus
whether they contribute to control of HCV replication in chronic
hepatitis C or explain the wide variation in viraemia between individ-
uals is not known. Similarly, although virus-specific CTLs are con-
centrated within the liver in chronic infection29,30,32, they have only
inconsistently been correlated with disease severity29,31. Some studies
have documented an association between elevated transaminases and
liver infiltration by CD8+ T cells31,33, but it is possible that only a minor-
ity of the infiltrate is HCV specific34. Intrahepatic pro-i flammatory
cytokine messenger RNA (mRNA) levels have been correlated with
severity of portal inflammation and liver fibrosis35,36. However, it is
unclear whether HCV-specific liver infiltrating lymphocytes are the
major cellular source of pro-inflammatory cytokines, such as IFN-!,
in HCV-associated chronic hepatitis36. Importantly, recruitment of
other inflammatory cell types such as macrophages that can mediate
tissue injury also occurs in chronic hepatitis C36. Thus, studies to weigh
the contribution of both antigen-specific and antigen-independent
mechanisms in chronic hepatocellular injury are needed.
Parsing T-cell responses in resolving and persistent infections
Features that distinguish T-cell responses providing transient versus
permanent viral control are not fully defined. Comparisons have
focused on the number of epitopes targeted by acute-phase T cells,
their frequency in blood and their fate as infections clear or persist.
CD8+ T-cell responses are perhaps th  best characterized. Successful
responses generally target multiple major histocompatibility complex
(MHC) class I-restricted epitopes in structural and non-structural
HCV proteins9,24,37,38, and frequencies against individual epitopes often
exceed 3–4% (ref. 37). Interestingly, late expansion of HCV-specific
CD8+ T cells may be accompanied by a further delay in their produc-
tion of IFN-!22,24,37, although the significance of this phenomenon to
infection outcome is uncertain.
Infections that follow a chronic course are usually marked by low
frequencies of CTLs targeting few epitopes28,39–42, although occasion-
ally the strength and breadth of the response can approximate those of
resolving infections43. HCV-specific CTLs are not necessarily deleted
as infections persist and, although difficult to detect in blood, can sur-
vive in the persistently infected liver for years29,30,32,44,45 and in some
cases target a surprisingly broad array of epitopes. For example, intra-
hepatic CTL populations recognizing eight HCV epitopes were con-
sistently recovered from a chimpanzee throughout years of persistent
infection45,46, and CTL clones isolated at diverse timepoints often
retained use of identically recombined T-cell receptor (TCR) " and #
chains47, providing genetic evidence of their remarkable stability
despite ongoing viral replication. These intrahepatic populations are
almost certainly a remnant of a once robust acute phase response.
Strong CD8+ T-cell immunity in acute resolvi g hepatitis C is
matched by vigorous, sustained CD4+ T-cell proliferation to multiple
recombinant structural and non-structural viral proteins19–21. By con-
trast, HCV antigen-driven proliferation in individuals who develop
persistent infections is usually weak or absent when compared with
spontaneously resolving infections19–22. Nevertheless, transient CD4+
T-cell proliferative responses that are indistinguishable from those in
acute resolving infections have been described21,22, and although pos-
sibly rare do indicate that HCV can evade what appears to be initially
Liver damage is monitored by levels of hepatic enzymes (transam-
inases) released into the serum following hepatocellular injury. Acute
hepatitis C is probably immunopathological because it coincides tem-
porally with expansion of virus-specific CD8+ T cells or cytotoxic T
lymphocytes (CTLs)9,22–24 and their acquisition of an activated pheno-
type25. Curiously, acute infection can sometimes resolve without a
serum transaminase increase. This could reflect non-cytolytic control





















Figure 1 | Schematic representation of the cellular immune response during
acute HCV infection. a, Viraemia (red line) is present early, and although it
usually falls from peak levels, it is never controlled. Persistent infection
ensues, with plasma vi al levels that vary widely between individuals. CD4+
and CD8+ T-cell responses (black and green lines, respectively) and rises in
serum transaminase (blue) in this setting remain poorly characterized, and
may be weak or even absent. Progressive shading indicates the high degree of
variability in responses between individuals. b, Viraemia may persist for
many weeks in the absence of a demonstrable cellular immune response. The
delayed onset of CD4+ and CD8+ T-cell responses is associated with transient
control of viraemia and a variable rise in transaminases. However, following
contraction of the CD4+ T-cell response, viraemia rebounds and ultimately
infection persists. Detectable CD8+ T-cell responses may persist despite
chronic viraemia. Shading indicates variability in viral load between
individuals in the chronic phase. c, Although viraemia arises early and T-cell
responses are delayed, the virus becomes undetectable in plasma following
emergence of CD4+ and CD8+ T-cell responses, which are often coincident
with a variable rise in serum transaminases. A rebound in viraemia may occur
before final viral clearance. 
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Figure 2. Schematic representation of the immune r sponse during 
chronic infection. Persist nt viral infection rebounds following cellular 
immune response due to many contributions (i.e., inhibitor molecules, 
exhaustion of T c lls, a d/or viral utations). Adapted and modified from [6]. 
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epitope at the MHC groove, thus escaping immune response of this variant. Other results 
of single amino acid substitutions, when taken place at non-anchoring residues, leads to 
TCR residues to form loose interaction with the pMHC leading to an improper immune 
response to the target infected cell [10]. The latter strategy involving non-matching of 
TCR and pMHC specificity is a common mechanism of viral mutations observed in 
various viral infection, particularly in HCV [28, 29]. 
 HCV genome is RNA encoded and it has been known to have a very high 
replication rate. However, the NS5B, an RNA-dependent RNA polymerase found in 
HCV virions, lacks proofreading function leading to various viral mutations potentially 
resulting in chronic infection [30]. The resulting mutations can contribute to different 
molecular mechanisms allowing escape from immune cell response. For example, the 
mutations of amino acid at MHC binding anchors attenuate binding of the entire peptide 
to the MHC molecule. Mutations at other hotspots can result in weak to even absence of 
TCR recognition. Primarily, viral mutations seen by any amino acid sequence alteration 
of the epitope that normally forms strong contact by the TCR residues, thereby 
preventing recognition or loose recognition of the epitope MHC class I complex by 
specific CTLs (Figure 3). This disruption leads to non-matching of the specificity of the 
TCR to the epitope and this common mechanism of viral mutations leading to its escape 
from immune cells is highly observed to that of chronic viral infection, particularly HCV 
[16]. 
 However, T cells adapt to theses variations with their own capability of 
addressing such mutations, and one such example is at TCR specific to NP418-426 
epitope of HLA-B*3501 in the case of an influenza viral infection [10]. TCR undergoing 
variations of such cases indicates signs of antigenic drift and emphasizes the ability to 
optimally recognize viral mutations to induce proper CTL response initiated by release of 
IFN-γ to block viral replication [31, 32]. Additionally, generated TCR variants has shown 
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to be compatible forming cross-reactivity against contemporary historical viral strains 
[33].  
 
2.1.6 T cell development memory markers  
 Over the course of the viral immune response, naïve T cells undergo three phases 
following an antigen encounter: (1) expansion/activation, (2) contraction/death, and (3) 
memory/maintenance [34]. During the peak of the viral immune response, CTLs become 
heterogeneous both phenotypically and functionally. Early memory markers are classified 
as either short-lived effector cells (SLECs)or memory precursor effector cells (MPECs). 
Figure 3. Viral epitope perturbation leading to ineffective CTL response. 
Mutations in viral epitope disrupting TCR contact residues leads to ineffective 
TCR recognition as shown in (1), or mutations of the anchoring residues of the 
epitope disrupts the affinity between the viral epitope and the MHC protein 
resulting in loss of a pMHC complex as shown in (2). In addition, viral tegument 
proteins can influence cellular machinery process to present viral epitopes on the 
surface and this can be achieved at steps involving proteasome and of transporter 
associated with antigen processing as shown in (3) and (4), respectively. Adapted 
from [10]. 
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SLECs are high in abundance compared to that of MPECs during the peak of the immune 
response, but they quickly perish following viral clearance. MPECs plays a central role in 
developing into memory population (Figure 4) [8, 35, 36]. 
 
2.1.7 Cytomegalovirus  
 Cytomegalovirus (CMV) is classified as a member of the Betaherpesvirinae sub- 
family of Herpesviridae and although the infection is persistent, it is asymptomatic. It 
infects 50-85% of adults by the age of 40 and virus has evolved to live in equilibrium 
with some cells and is typically in latent state of infection. However, 
immunocompromised individuals with CMV infection can lead to morbidity and 
mortality. The virus has a double-stranded DNA inside an icosahedral protein capsid. 
Mamammalian target of 
rapamcyin
(mTOR). A serine/threonine 
protein kinase that regulates 
cell metabolism, proliferation, 
survival, protein synthesis and 
transcription. It is activated by 
T cell receptor signalling and  
is sustained by inflammatory 




(AMPK). A negative regulator 
of mammalian target of 
rapamycin (mTOR) kinase 
activity. It is activated in 
response to cellular stress  
and ATP deprivation. It can  
be also activated by the 
pharmacological agent 
metformin.
of the pTReg cell transcriptional programme has gained 
increasing attention. There is the possibility that a 
pTReg cell could gain the effector profile of a TH1 cell 
in a dominating TH1 cell-associated environment. A 
recent study showed that T-bet+ pTReg cells express 
10–20-fold less T-bet than conventional TH1 cells even 
in TH1-type inflammatory conditions80. The low level 
of T-bet expression in pTReg cells is maintained by the 
silencing of the Il12rb2 locus, which prevents T-bet+ 
pTReg cells from completing IL-12R–STAT4-dependent 
TH1 cell differentiation. This maintains the suppressive 
function of these cells without the production of pro-
inflammatory cytokines79. However, T-bet expression in 
pTReg is absolutely essential for their proper migration. 
T-bet induces the expression of CXCR3 — a TH1 cell- 
associated chemokine receptor — which enables T-bet+ 
pTReg cells to migrate to sites of TH1 cell-mediated 
inflammation and to suppress local TH1 cell responses.
Although Tbx21 encodes the TH1 cell lineage-
specifying transcription factor, the promoter of the 
Tbx21 gene is marked by permissive and repressive 
genetic marks in TH2, TH17, TFH and pTReg cells, and it 
is poised for subsequent activation or silencing71,73,77. 
Maintenance of the master transcription factor loci 
in a poised, bivalent epigenetic state in the opposing 
TH cell subsets is the basis for functional plasticity of 
CD4+ TH cells, which respond to changes in the envi-
ronment by adopting the gene expression profiles of 
other TH cell lineages73. T-bet has a dominant role, often 
tipping the balance towards a TH1 cell phenotype. As 
described in the aforementioned examples, sometimes 
the acquisition of TH1 cell properties is accompanied 
by the repression of the existing gene expression profile 
(in the case of TH17 cells). In other cases, the respond-
ing TH cell subset gains features of the TH1 cell line-
age, such as IFNγ and CXCR3 expression, but keeps its 
genetic profile (in the case of TH2, TFH and pTReg cells). 
Functional plasticity of CD4+ TH cells could be one 
mechanism to provide maximum host protection by 
generating large numbers of TH1 cells from pre-existing 
TH cell subsets following infection with intracellular 
pathogens. However, in the case of pTReg cells, increased 
T-bet expression is required for proper migration of 
pTReg cells to sites of TH1-cell dominated responses to 
minimize the amount of immune-mediated pathology.
Generation of B cell and T cell memory
T-bet in CD8+ T cell memory. The acquisition of CD8+ T cell 
effector functions and the development of CD8+ 
T cell memory (BOX 2) are crucially dependent on 
transcriptional events that are regulated by T-bet and 
EOMES. CD8+ T cells that lack either T-bet or EOMES 
show a minor defect in their effector functions, which 
suggests that these two transcription factors have over-
lapping and partially redundant roles in establishing 
the differentiation programme of CD8+ T cells81,82. 
However, CD8+ T cells that are deficient in both T-bet 
and EOMES lose their cytotoxicity and aberrantly pro-
duce large amounts of IL-17A in response to infection 
with LCMV83. T-bet expression is rapidly induced by 
TCR and IL-12R signalling, and is required for the 
early production of IFNγ and granzyme B (encoded 
by Gzmb) by antigen-specific CD8+ T cells84,85 (FIG. 5). 
EOMES, which is induced later in a RUNX3-dependent 
manner, can substitute for T-bet to promote IFNγ and 
granzyme B expression and, together with STAT5, 
regulates perforin gene expression in CD8+ T cells84,86 
(FIG. 5a). The concerted action of T-bet and EOMES 
results in the development of fully differentiated effec-
tor CD8+ T cells that migrate to inflamed tissues and 
that, following antigen recognition, secrete cytokines 
(for example, IFNγ and TNF) or lyse infected cells by 
releasing cytotoxic granules that contain granzymes 
and perforin.
T-bet and EOMES have essential but reciprocal roles 
in regulating effector and memory T cell differentia-
tion pathways87–89 (BOX 2; FIG. 5b). Inflammatory signals 
that are present during CD8+ T cell priming define a 
gradient of T-bet and EOMES expression and, conse-
quently, influence the fate of effector CD8+ T cells87. 
Strong IL-12R signalling provides the instructive 
signal for the terminal differentiation of short-lived 
effector cells (SLECs) by enhancing and maintain-
ing STAT4-mediated mammalian target of rapamycin 
(mTOR) kinase activity. This functions as a molecular 
switch to concomitantly induce T-bet expression and 
to repress EOMES expression through the inhibition of 
FOXO1 transcriptional activity85,88,89. Thus, T-bet defi-
ciency, IL-12 deficiency or inhibition of mTOR activ-
ity results in a profound absence of SLECs and in the 
Box 2 | CD8+ T cell memory
When a naive CD8+ T cell encounters an antigen, it undergoes a differentiation 
programme that can be divided into three main developmental stages: clonal expansion 
and differentiation, contraction, and memory formation. The differentiation process that 
occurs at the peak of the response generates quite a heterogeneous population of CD8+ 
T cells, which have different fates and memory cell developmental potential. Short-lived 
effector cells (SLECs) are terminally differentiated effector cells that express low levels 
of interleukin-7 receptor-α (IL-7Rα) and high levels of killer cell lectin-like receptor 
subfamily G member 1 (KLRG1) and IL-2Rα. By contrast, memory precursor effector cells 
(MPECs), which give rise to long-lived, self-renewing memory CD8+ T cells, express high 
levels of IL-7Rα and low levels of KLRG1 and IL-2Rα. After an infection is cleared, the vast 
majority of antigen-specific CD8+ T cells that are generated during clonal expansion die. 
The cells that survive the contraction phase, the MPECs, go on to generate a reservoir 
of memory CD8+ T cells. Memory T cells can be either effector memory (T
EM





 cells (KLRG1hiIL-7RαhiCD62LlowCCR7low) monitor and 
guard peripheral tissues from reinfection by providing an immediate effector response, 
whereas T
CM
 cells (KLRG1lowIL-7RαhiCD62LhiCCR7hi) reside in lymphoid tissues and give 
rise to a large nu ber of secondary effector cells during recall responses.
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Figure 4. Schematic of CD8+ T cell immune response. Following viral 
infection, cognate CD8+ T cell develop into various subset both for short 
and long term homeostatic maintenance. Following expansion, T cell go 
through an early display of memory markers that sets precedent for the 
memory population and these distinct marker specific T cells exhibit 
different function. Adapted from [8]. 
 12 
Between the capsid and the outer lipid envelope contains proteinaceous tegument.  The 
virus infects epithelial cells, B cells and monocytes [37]. 	
	 The virus binds to the cell surface by forming an interaction between 
glycoproteins on the virion envelope and the heparin sulfate proteoglycans found on the 
cell surface. Followed by the fusion that takes place involving the envelope of the virion 
and the plasma membrane of the cell, the capsid and associated tegument proteins are 
released into the cytoplasm. The dynein inside the cytoplasm mediates the movement of 
these viral proteins to the nucleus allowing the double-stranded viral DNA enters the 
nucleus through the nuclear pore [15, 38]. The viral genomic DNA is encapsulated inside 
an icosahedral protein capsid and between this capsid and the outer lipid envelope 
contains proteinaceous tegument. Some of these tegument proteins are responsible for 
modulating the infected cell that disrupts the immune response during viral immune 
response of the host. The most abundant tegument protein, phosphoprotein 65 (pp65), is 
responsible for modulating the host cell immune response during CMV infection (Fig. 2). 
As importantly, it also serves as the immunodominant antigen for CD8+ T cells and the 
epitope that is most prevalent of this antigen is NLVPMVATV peptide [15].  
2.1.8 Lymphocytic choriomeningitis virus  
 Lymphocytic choriomeningitis virus (LCMV) carries RNA as its genome that 
gains entry into cell by binding the glycoprotein of virion to the α-dystroglycan found on 
the cell surface [39]. LCMV is a common pathogen for house mice, but humans can be 
infected as well and this common pathogen causes inflammation in the meninges lining 
the brain and spinal cord [33]. Two common strains of LCMV are Armstrong (acute) and 
Clone 13 (chronic) that are widely used to study in mice to understand viral infection 
progression and how that influences immune response. The most prominent peptide used 
for this model is glycoprotein 33 (gp33) [39]. The Armstrong infection elicits a unique 
kinetics different from the chronic strain, Clone 13 and alongside elicits an immune 
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response composed of diversified clones of cognate specific T cells recognizing various 
portions of the virus. When naïve CD8+ T cell interacts with its cognate antigen, an 
induced T cell immune response is initiated that can be divided into three phases 
involving (1) activation and expansion of cognate populations, and after the peak of the 
response (7-8 dpi), (2) contraction of the expanded population begins, and (3) the 
surviving populations contribute to the maintenance for the memory population (Figure 
6) [9, 34, 40, 41]. 
2.1.9 Spleen 
Lymphoid organs play a central role in facilitating the lymphatic system, which 
maintains host fluid balance, transportation, and works along the immune system. Sites 
associated with accumulations of lymphoid cells are coined primary and secondary 
lymphoid organs (SLOs). Primary lymphoid organs generate functionally mature naïve 
lymphocytes in the absence of foreign antigens, whereas SLOs are sites that responds to 
foreign antigen invaders [42]. SLOs initiate the adaptive immune responses, in which 
APCs, such as dendritic cells and macrophages, capture pathogens and bring these APCs 
in close contact with cognate lymphocytes. This interaction provides a niche for 
Figure 5. Various epitope-specific CD8+ T cell clones from activation into 
memory phase of the immune response. Total numbers of GP33- (●), GP118- (○), 
GP276- (▲) and GP92- (△) specific CD8+ T cells per spleen. Adapted from [9]. 
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differentiation to take place for the immune cells within the host to limit the spread of the 
infections (Figure 6) [43]. The spleen, being the largest SLO, plays an essential function 
to counteract against circulating antigens. Spleen is compartmentalized distinctly into two 
compartments: WP and RP. Blood enters the spleen carrying antigens and other 
components and macrophages that reside in WP at the marginal sinus capture these 
pathogens. Blood components continue to travel through the marginal zone in a direction 
away from the WP regions into the RP to return to the vasculature network via venous 
sinuses [44]. 
The function of leukocytes in the spleen, depending on the localization, conduct 
discretely. RP macrophages phagocytose aging RBCs and regulate iron recycling and 
release, whereas marginal zone macrophages utilize patter-recognition receptors to 
remove a subset of bacteria and viruses. Residents at marginal zone, like B cells and 
dendritic cells, along with the macrophages, also uptake antigens and migrate to WP for 
antigen presentation. Entrance to WP is restricted to a subset of cells (B cells, dendritic 
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and CD209b (SIGN-R1, a DC-SIGN homolog), and are well placed 
microanatomically to capture blood-borne antigens46,100,101,103. 
Marginal zone macrophages have been shown to regulate the reten-
tion of marginal zone B cells, a process in which MARCO is impli-
cated107. B cells in turn are needed to establish the architecture of the 
splenic marginal zone100,101. The development of both marginal zone 
and metallophilic macrophages is regulated by the nuclear receptor 
LXR1  (encoded by Nr1h3)108.
The ‘metallophilic’ or ‘marginal zone metallophilic’ macrophages, 
present in the ‘inner layer’ of the marginal zone are identified by 
discrete expression of select markers, such as CD169 (sialoadhesin 
or Siglec-1; sialic acid–binding Ig-like lectin-1). The initial observa-
tion that metallophilic macrophages produce type-I interferon after 
viral infection suggested a role for them in antiviral responses109, 
but roles in bacterial infection have also been proposed110. One 
study of vesicular stomatitis virus showed that the type 1 interferon 
response is suppressed in metallophilic macrophages, which allows 
them to become a reservoir of replicating virus that drives an effective 
adaptive immune response111. Targeting of antigen to metallophilic 
macrophages appears to facilitate the generation of cytotoxic T cells 
after transfer of blood-borne antigen or adenovirus to CD8+ dendritic 
cells112. Collectively, these studies indicate that the marginal zone 
and metallophilic macrophages act in immune surveillance and are 
excellently positioned to capture blood-borne pathogens and regulate 
the subsequent adaptive immune responses.
In the splenic white pulp, macrophages can be identified by their 
expression of the pan macrophage marker CD68. Among these, 
tingible body macrophages present in the germinal centers were 
named based on their histochemical staining pattern. Their ‘unique’ 
staining results from apoptotic cell debris and associated chromatin, 
which is derived from the phagocytic clearance of dead, activated 
lymphocytes that result from the germinal center reaction99. MFG-E8 
and the receptor tyrosine kinase Mertk113 are important for the clear-
ance of apoptotic cells by tingible body macrophages. In this setting, 
germinal center defects in apoptotic cell clearance have been suggested 
to cause alterations in tolerance of B cells and lead to the production of 
autoantibodies80,113.
Conclusions
Transcriptional profiling of macrophages from different tissue loca-
tions, from the embryo to the adult has identified, and will con-
tinue to identify, core features of tissue-resident macrophages17,32. 
This approach has been validated by the identification of Spi-C 
transcriptional networks in splenic red pulp macrophages after the 
discovery that Spi-C has a critical role in development of red pulp 
macrophages102. It is reasonable to assume that there will be many 
discrete transcriptional controls for individual tissue-resident macro-
phage populations. Transcription factors and epigenetic regulators 
will be identified that are not just important for the development of 
tissue-resident macrophage populations but that regulate key func-
tional characteristics of those cells and without which their character-
istic phenotype would be markedly altered. This will begin to explain 
the extreme diversity and heterogeneity seen both between and within 
distinct tissue-resident macrophage populations.
Furthermore, understanding the distinct developmental origins of 
many tissue-resident macrophage populations, including their need 
for renewal during homeostasis and disease, will provide insights into 
fundamental differences between inflammatory monocyte-derived 
macrophages and their tissue-resident ‘cousins’. At this time, it is not 
known whether the distinct origins of tissue macrophages (for example, 
yolk sac versus hematopoietic) has any impact on the function of 
the resultant tissue macrophages. At the very least, one may expect 
that the requirement for the mature prenatally derived cells to exist 
in a seemingly quiescent state and yet remain competent to prolifer-
ate as a mature cell (during homeostasis or inflammation) must be 
under defined transcriptional control. This control, which itself will 
be refined by local environment-specific factors, will undoubtedly 
impact the function and phenotype of the cell. Defining key transcrip-
tional control elements should provide opportunities to manipulate 
one branch of the ‘family’ preferentially, for example, to modulate the 
activity of inflammatory monocyte-derived macrophages while limit-
ing impact on homeostatic tissue-resident macrophage functions and 
vice versa. A herculean effort will be needed to extrapolate the findings 
from global transcriptomic and elegant fate-mapping studies to dis-
crete clinically relevant settings, in specific tissues. Ultimately this will 
identify new mechanisms through which tissue-resident macrophages 
may be manipulated for therapeutic benefit, not simply in the context 
of immune disease but in regulation of tissue physiology in general.
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Figure 3 Microanatomy of the mouse spleen 
showing discrete localization of splenic 
macrophage populations. The mouse spleen has 
discrete red and white pulp regions separated by 
a marginal zone (MZ). The macrophages (M ) of 
the spleen are shown in their distinct anatomical 
locations. The red pulp macrophages (indicated 
immunohistochemically by F4/80 expression: 
red, top) are involved in iron processing. 
Marginal zone and metallophilic macrophages 
(indicated in immunohistochemistry images 
(bottom left) by SIGN-R1 and CD169 
expression, respectively) have roles in the 
capture of microbes and viruses from the 
circulation. Tingible body macrophages in the  
B cell follicles clear the apoptotic cells that  
result from the germinal center (GC) reaction.  
FDC, follicular dendritic cell. Immunofluorescence 
images were provided by H. Veninga, E. Borg,  
G. Kraal and J.M.M. den Haan.
Figure 6. Mouse spleen microanatomy depicting WP and RP and its 
localization of its residents. WP and RP are functionally and morphologically 
distinct compartments. WP contain a wider variation of cellular populations (i.e., 
CD4+ and APCs) in comparison to RP. Adapted from [7]. 
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cells, CD4+ and CD8+ T cells) and components exit out of spleen mostly via splenic vein 
in the RP, however some cells from WP exit via a local network of efferent lymphatic 
vessels that connects to the other parts of the host [45].  
2.2 Significance 
T cell activation and priming is an important feature of the immune response of 
the host to effectively clear viral pathogen and establish homeostasis. Particularly, 
interest in characterizing the dynamic changes of the TCR binding kinetics influenced by 
organ structures and as result, the impact ligand recognition is highlighted in this study. 
This study also aims to elucidate the mechanism driving the effects on TCR-pMHC 
kinetics both by in-vivo and in-vitro conditioning. Viral infection to the host also poses 
problems that stem from viral mutations, which occurs to increase viral fitness by 
evading immune responses. The potency of these viral mutations binding is typically 
determined by lysis response assays and the affinity or avidity measurements of the 
mutated pMHC to the host sample. However, the measurements are provided using 3D 
assays, thereby not even proximally mimicking the natural interaction that takes place 
within the host. This study also aims to investigate the kinetic parameters mimicking 
natural interaction setting (as in utilizing the full cell) by characterizing affinity and 
correlating the findings with functional assay. More importantly, the contribution of force 
on bond-lifetime is highlighted in the context of viral mutants with the capability to lower 
cytolytic responses of CTLs. The resulting insights of this study provides evidences to 
understand how to optimize interaction with viral variants to effectively trigger cytolytic 
function on how to improve vaccine and through emerging technologies, such as, 
chimeric antigen receptors. Overall, this study will contribute to describe how viral 
epitopes and leukocyte interaction impact on recognition or tolerance upon infection 
using binding kinetics providing a unique perspective to the field of immunoengineering. 
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1 Reagents 
3.1.1 Proteins  
For the LCMV and CMV study, we used synthesized recombinant peptides from 
Genemed Synthesis Inc. and pMHC monomers were developed by the National Institutes 
of Health Tetramer Core Facility at Emory University. For LCMV study, the peptide 
sequences were glycoprotein (gp33) (KAVYNFATM), gp35A/V35A (KAAYNFATM), 
and gp276 (SGVENPGGYCL) bound to H-2Db or a mutant H-2Db (the a3 domain in 
mouse H-2Db is replaced with the a3 domain of human HLA-A2) [46, 47]. For CMV 
study, the peptide sequences were CMV pp65 NLV (NLVPMVATV), T8V 
(NLVPMVAVV), and M5I (NLVPIVATV) bound to HLA- A*02:01 or a mutant HLA-
A*02:01 (the heavy chain of D227K/T228A in the a3 domain of HLA-A*02:01 that 
appear to be important for the interaction with CD8) [48-50]. All these pMHC monomers 
are biotinylated on the C-terminus. Biotinylated anti-TCR was used to determine the 
adhesion frequency and 2D affinity to P14 TCR on P14 T cells. 
For the LCMV study, CD4 ablation was proceeded by intraperitoneal 
administration of CD4-depleting antibody (GK1.5, 500 µg/mouse) at 1 day before 
infection and 0 dpi on C57BL/6 [51-54]. As for FoxP3-DTR mice, FoxP3+ Treg was 
depleted by intraperitoneal administration of diphtheria toxin (1 µg/mouse) at 7, 8, and 
10dpi. As for inhibiting the effect of TGF-b signaling, C57BL/6 mice were treated with 
TGF-b inhibitor (SB431542, 20 mg/KG•mouse) intraperitoneally at 8, 9, and 10 dpi. 
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Lipid raft disruption was performed in-vitro through two means: sequestration and 
depletion of cholesterol. Cholesterol sequestration on splenocytes was performed by 30 
min incubation of nystatin (25 µg/mL) at 37 °C prior to Fluorescence activated cell 
sorting (FACS) cells, whereas cholesterol depletion was performed by incubating 
splenocytes with cholesterol oxidase (5 U/mL) for 30 min at 37 °C prior to sorting cells. 
Unlike nystatin treatment, cholesterol oxidase was present during micropipette assay. 
3.1.2 Protein coating on RBC surface 
Purification of human RBCs from peripheral blood of healthy donors at Georgia 
Institute of Technology with protocol approved from Institute Review Board [55-57]. 
Purified RBCs were biotinylated with various concentrations of Biotin-X-NHS (EMD) 
and stored in Experimental additive solutions 45 (EAS-45) buffer over a period of 4-6 
weeks. To link biotinylated proteins on RBCs, biotinylated RBCs were initially incubated 
with streptavidin at 1mg/ml final concentration in room temperature (RT) for 20 mins. 
After incubation period, excess unbound streptavidin is washed off by washing three 
times, after which streptavidin coated-biotinylated RBC is incubated with the biotinylated 
protein (pMHC or antibodies) for an additional 20 min at RT, followed by washing 
similar to washing off excess streptavidin.  
3.1.3 Site density measurements 
Biotinylated proteins on RBCs were determined by flow cytometry to obtain the 
2D effective affinity [55-57]. PE-conjugated monoclonal primary antibodies or secondary 
antibodies were stained on RBCs to measure site densities of pMHCs or anti-TCR and T 
cells for CD8 or TCR site densities. The measured MFI for each sample measured is 
converted to the number of molecules per surface area (µm2) based on PE calibration 
beads with known number of PE molecules. As T cells undergo change in size during the 
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course of the infection, the size of T cell was measured for every 2D micropipette 
experiment. However, RBC size was kept constant for all experiment. 
3.2 Assays 
3.2.1 Animal and cell for LCMV study 
For understanding the role of spleen compartmentalization, P14 TCR transgenic, 
C57BL/6 and FoxP3 DTR mice were utilized and housed at Yerkes National Primate 
Research center at Emory University according to institutional approved protocol by 
Institutional Animal Care and Use Committee. P14 TCR recognize gp33 epitope of 
LCMV Armstrong clone. Transgenic P14 CD8+ T cells were adoptively transferred to 
either C57BL/6 or FoxP3 DTR mice and was infected with LCMV Armstrong 
intraperitoneally with 2×105 plaque-forming unit. Adoptively transferred transgenic P14 
T cells display specific markers not endogenously present within the adoptively 
transferred host allowing cells to be tracked once transferred. Several days following 
infection, fluorophore-conjugated antibody against Thy1.1+ or CD45.1+  is intravenously 
(i.v.) injected to the host (3 µg/mouse) to tag P14 T cells in vasculature and after few 
minutes, the host is sacrificed 3 min after antibody injection to prevent staining of P14 T 
cells embedded within tissue such as WP. Harvested spleens were then stained ex-vivo 
using antibody against Thy1.1 or CD45.1 with a different fluorophore conjugated from 
the i.v. injected. Using BD FACSAriaTM, stained P14 samples were sorted from splenic 
RP (i.v. and ex-vivo double positive) and splenic WP (i.v. negative, ex-vivo positive) 
(Figure 7). Furthermore, additional antibodies were stained for memory markers 
following spleen harvest with KLRG-1high/CD127low expressing cells categorized as 
SLECs and cells expressing KLRG-1low/CD127high as MPECs. Sorted cells were washed 
and stored in PBS with 2%FBS in 4 °C for use up to 24hrs. 
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3.2.2 CMV positive-specific T cells by in vitro enrichment from PBMCs 
Peripheral blood mononuclear cells (PBMC) of CMV positive HLA-A2+donors 
were isolated and incubated with 10 µg/ml NLV peptide in primary culture. Cells were 
maintained by the addition of 50 U/ml human recombinant IL-2 every 2-3 days. After 2-3 
weeks of culture, a polyclonal enriched peptide-specific CTL lines from each donor was 
established and cells were stained with NLV-tetramer to validate increased frequency of 
NLV-specific population. For conducting 2D biophysical experiments and DNA force 
probe experiment, the enriched samples were stained with antibodies against CD3 and 
CD8 using different fluorophores to obtain a higher degree of purified NLV-specific 
population. Briefly, a small portion of the PBMC with antibodies against CD3 and CD8 
was aliquoted to another tube and was stained additionally with NLV-tetramer 
conjugated with a different fluorophore. This sample was initially run to determine the 
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be a useful approach to identify this 
population for further characterization. 
Permissiveness to intravascular Ab 
labeling in additional tissues will be 
shown in Figure 4. In summary,  
perfusion is unnecessary if intra-
vascular staining is incorporated, and 
neglecting to perfuse has advantages.
Intravascular staining reveals unique 
lymphocyte subsets in tissues
Intravascular staining can also be used 
in the context of polyclonal endog-
enous CD4 and CD8 T-cell responses. 
For example, 12 d after i.t. LCMV  
infection, H-2Db/gp33 MHC I tetramers 
a d I-Ab/gp66 MHC II tetramers were used to identify LCMV-specific CD8 and CD4 T cell responses, respectively (Fig. 4a).  
In this case, vascular T cells were identified via injection of anti-CD45.2 mAb, but mice were not perfused. All examined  
tissues contained LCMV-specific CD8 and CD4 T c lls that were labeled by i.v.-injected mAb (Fig. 4b,c), and immunohisto-
chemical analysis confirmed that T cells exposed to i.v. mAb were associated with CD31 +  blood vessels in NLT  
(Supplementary Fig. 1). Consistent with reports that CD69 expression on T cells is a marker of tissue residence9,10,38,47,48, 
CD69 +  T cells were only found in the compartment of NLT protected from the i.v. mAb, with the exception of cells isolated 
from the liver. These results are in keeping with published reports suggesting that liver may contain a fraction of sinusoidal 
resident CD8 T cells9,14. CD69 expression profiles in tissues were similar 12 and 30 d after infection (data not shown).  
The proportion of i.v. protected LCMV-specific CD4 T cells in tissues is typically greater than that observed for CD8 T cells, 
particularly in the lung (Fig. 4d and Supplementary Fig. 2).
In the context of M. tuberculosis infection, intravascular staining also discriminates between the function and phenotype 
of local T cells truly within the lung as compared with those in vasculature (Fig. 4e and data not shown). M. tuberculosis 
causes a chronic lung infection that is contained, but not eliminated, by local immune responses. Twelve-week-old C57BL/6 
mice were infected with 100–150 c.f.u. of aerosolized M. tuberculosis (strain H37Rv); anti-CD45.2 mAb was injected i.v. 24 d  
later, and leukocytes from the lungs, bronchioalveolar lavage (BAL) of the lung airways and blood were evaluated.  
Intravascular s aini g confirms that I-Ab ESAT-61-20 and KbTB10.3/44-11 te ramer +  T c lls (which identify M. tuberculosis– 
specific CD4 and CD8 T cells, respectively) have varied PD-1 expression, a receptor that inhibits T cell function and is regulated 
by antigen st mul tion (Fig. 4f,g). Among both antigen-specific CD4 a d CD8 T cells, PD-1 is more hig ly expressed on cells 
protected from intravascular staining compared with i.v. labeled cells present in vasculature (Fig. 4h). These data reinforce 
that intravascular staining has the potential to refine our understanding of local immune control over M. tuberculosis.
g
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Figure 3 | Intravascular staining is confined 
to vascular cells. (a) Schematic of intravascular 
staining. (b–g) Anti-CD31 and anti-CD45.2 (b) 
or anti-CD45.2 mAb alone (c–g) was injected i.v. 
into C57BL/6 mice 12 d after i.t. LCMV infection. 
(b) Confocal imaging of lung, anti-CD31 i.v. 
(green), anti-CD45.2 i.v. (red), anti-CD8   
(cyan) and DAPI (gray). Representative of  
three experiments totaling four mice.  
(c–e) iBALT (c), alveolar lymphoid aggregates (d) 
and intraepithelial lymphocytes (IEL) (e) in the 
lung 12 d after i.v. LCMV infection. Orange arrows 
indicate sample IELs. (f) Inguinal lymph node 
sections showing anti-CD45.2 i.v. mAb staining 
(red) and ex vivo anti-CD31 (cyan), anti-CD8  
(green) and DAPI (gray). (g) White inset from f 
without DAPI displayed. Yellow arrows indicate 
anti-CD45.2 i.v. and anti-CD8  mAb co-staining. 
Scale bars, 100 m. (c–g) Data are representative 
of three experiments totaling nine mice. 
Sort 
Figure 7. Experimental scheme for adoptive transfer. P14 T cells were 
adoptively transferred into B6 mice one day before infection with LCMV-Arm 
and isolated on indicated dpi from WP or RP. Prior to sacrificing mice, 
fluorophore conjugated antibody targeting transgenic markers on adoptively 
transferred P14 cell  by intravascular staining. An ex-vivo antibody with a 
different fluorophore is added to the spleen sample after mouse is sacrificed. The 
sample is gated of the two contours and then sorted, respectively. Adapted and 
modified from [3]. 
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peptide resulted in a subpopulation of cells at various stages of activation, the more 
activated state has been correlated with downregulated CD3 expression. This along with 
high CD8 expression correlated with high frequency of NLV-specific T cells stemming 
from the tetramer staining (Figure 8). This CD3low/CD8high template was used to 
determine the percentage of CD3low population and this percentage value was used an 
initial value that was further lowered for the enriched PBMC sample containing 
antibodies-alone. The enriched PBMC sample containing antibodies-alone was primarily 
used to sort enriched NLV-specific T cells from the whole mixture. A lower CD3low 
percentage was set for the sorted sample primarily due to the absence of the third 
fluorescence (tetramer) in the sample, and thereby, ensuring increased purity of NLV-
specific T cells to conduct 2D biophysical assay and functional studies. All samples were 
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Figure 8. NLV tetramer frequency of CD3 population. Gating was set for 
lymphocytes, CD3low/high and CD8high. Grey arrows direct the pathway 
moving from one panel to the other. This template was used to do sorting of 
cells stained with CD3 and CD8 for various assays. 
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stained at 4°C and in rotation for 30 min to primarily lower the activation through CD3 
antibody. Following sorting, cells were washed and stored in PBS with 2%FBS in 4 °C 
for use up to 24hrs. 
3.2.2 2D micropipette adhesion frequency assay 
A customized inverted microscope (TMD Diaphot, Nikon) objective lens with 
two 3D micromanipulators (Newport) facing each other that holds capillary glass pipettes 
that was pulled (Sutter Instruments) and shaped using an in-house built forge. The 
pipettes are inserted into a chamber that contains L-15 media medium (Sigma-Aldrich) 
plus 5mM HEPES and 1% bovine serum albumin (BSA). The pipettes were connected to 
a home-made manometer system allowing negative pressure to aspirate and hold cells at 
the tip of the pipettes. Prior to applying suction pressure, pipettes were mounted on the 
manipulators and an individual RBC and T cell were aspirated, respectively and 
positioned facing each other (Figure 9). Using a piezo actuator controller, the aspirated 
RBC comes into contact with the T cell for a duration set by the user and then the RBC 
aspirated pipette is retracted using LabView software (National Instruments) and DAQ 
6008 (National Instruments). Using a CCD camera (MTI DC330, Dage), one of the two 
events were observed every cycle: (1) adhesion or (2) no adhesion. When the RBC is 
being retracted after contact and no elongation of the RBC is observed at the point of 
contact, then this particular cycle is categorized as an event where no adhesion has taken 
place. However, if during the retraction phase the RBC elongates and deforms prior to 
complete detachment from the cell, then this particular cycle is categorized as an 
adhesion event. The frequency of adhesion event (Pa) between the RBC/T cell pair 
contact is observed for 30 cycles. 
 By increasing the contact time (tc), an adhesion frequency curve is generated and 
along with the receptor/ligand densities, the data generated is fit using a nonlinear 
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regression to with least mean square method to the following probabilistic kinetic 
equation for a single-step monovalent receptor ligand interaction:  
𝑃" = 1 − exp −𝑚*𝑚+𝐴-𝐾" 1 − exp −𝑘011𝑡- }        (1) 
Two parameters are derived from the following equation using Excel solver: (1) 
zero-force off-rate koff (s-1) and (2) the 2D effective binding affinity, AcKa (µm4). The 2D 
effective affinity consists of two combined parameters, where Ka represents the 2D 
affinity and the Ac denotes the consistent contact area formed between the RBC and the T 
cell during impingement. 
 
For experiments where the primary objective is to measure the 2D effective 
affinity, the contact time is kept constant and the binding frequency is measured. This tc 





Figure 9. Micropipette adhesion frequency. RBCs coated with protein of 
interest is aspirated to one side of the pipette and the apposing pipette aspirates a 
leukocyte prior to contact. Biotinylated proteins are bound covalently to RBC by 
streptavidin. For the adhesion frequency assay, impinging apposing cells to form 
a contact and maintain for a certain duration and during retraction, the user 
visualizes if an elongation takes place to see if an adhesion even takes place. 
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approaches steady state, which will be termed tst. This allows equation 1 to be log 




                   (2) 
For measurements of tri-molecular interaction between TCR-pMHC-CD8 
binding, the right hand side of equation 2 represents the average number of bonds <n> 
(the numerator) per unit densities of TCR and/or pMHC. 
For the LCMV study, tst was set at 4 sec and for the CMV study, tst was set at 2 
sec. The respective tst for each system reached steady state in regards to the adhesion 
frequency. They were not the lowest tc to reach saturation. 
 To understand the level of non-specific adhesion that can stem from this 
technique, RBCs coated with streptavidin or with self-A2 HLA-A*02:01 was used to 
address non-specific binding. Binding frequency were less than 3% for biotin with 
streptavidin and also for RBCs with self-A2 HLA-A*02:01. 
3.2.3 Thermal fluctuation assay  
In order to obtain koff by performing thermal fluctuation assay, force clamp was 
set at low force (1pN) and a softer spring constant was set (0.25pN/nm) to obtain lifetime 
measurements. With the nystatin treated RBC acting as a soft spring constant and given 
the BFP’s high resolution, a more accurate measurement of the koff is obtained than the 
koff obtained through 2D micropipette adhesion frequency assay. 
Lifetime is measured for BFP [58, 59] using RBC that act as a force transducer. 
The nystatin treatment to RBC is a hypotonic treatment allowing RBC to swelling. The 
RBCs were biotinylated allowing streptavidin coated beads linked to biotinylated proteins 
to be placed on the RBC (Figure 10). The RBC is captured and held by a borosilicate 
micropipette termed probe pipette with controlled aspiration pressure. The streptavidin 
coated bead aspirated by the bead pipette allows the user to place the bead on the apex of 
the RBC. Based on the diameter of the pipette, the diameter of the RBC, and the length of 
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the interface between the RBC and the bead at the apex of the RBC is measured. These 
parameters determine the distance of the manometer to be placed to apply the negative 
pressure to set the spring constant of the RBC at 0.25-3 pN/nm. A third pipette termed 
target pipette has the cell aspirated and is faced apposing the target pipette. The target 
pipette is controlled by a piezo actuator allowing contact to be made with the bead. 
 
A high speed CCD camera with frame rate of 1,500 frames/s captures the 
greyscale profile of the interface of the edge between the RBC and bead complex. This 
allows to track the axial displacement of this profile following impingement and 
following retraction. Lifetime detection is described in detail in the force-clamp assay 
section. By converting the exponential component by taking the natural log results in the 
plotting the survival probability curve (natural log of the number of events at the 
specified lifetime). 
Tracker 
RBC				Bead	 	 T	cell 
Figure 10. Biomembrane Force probe assay. Video-micrograph of a 
BFP with an RBC ligand-coated bead reporter held facing a T cell 
aspirated to an apposing pipette. A swollen RBC is aspirated with a ligand 
coated bead that is mounted to the RBC apex. T cell bearing pipette is the 
target that is mounted to a computer-controlled piezo translator apposing 
bead mounted RBC. A tracker is placed at the interface of the bead and the 
RBC. 
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3.2.4 Force-clamp assay 
Following interaction with ligands, anchoring receptors must withstand 
mechanical forces projected by the environment (i.e. external fluid flow and tissue or 
substrate stresses) and by the internal cytoskeletal tension from receptor and ligand 
anchoring cells. Therefore, initially we wanted to understand how receptor-ligand 
interactions is influenced under force. 
Conventional methodology of force measurement composes of atomic force 
microscopy, optical tweezers, and BFP to understand the effect of force on bond 
interaction at a single bond level and ideally, in these experiments, surfaces are coated 
with either the receptor or the ligand to have them interact with their complement protein 
and the kinetic parameter is measured at the force. 
Using the BFP, force is loaded to a constant level and held until the bond breaks. 
If the average bond lifetime decreases as the force increases, the bond exhibits slip bond, 
presumably because force pulls out the ligand. However, as the average bond lifetime 
increases with increasing force up to a critical force, the interaction exhibits a catch bond 
and this region is called the catch regime. Above the critical force, even catch bonds enter 
domain is an allosteric activator of mannose-binding in
FimH [4]. Antibodies are not the only form of regulation,
however. Intact FimH incorporated into the native fim-
briae or fimbrial tips have 100-fold higher affinity for
soluble mannose than does isolated lectin domain. Point
mutations that inhibit the interdomain interactions acti-
vate FimH [5], as does a FimC chaperone protein that
binds the pilin domain at the interdomain interface [6].
Together, these results indicate that the pilin domain
down-regulates the lectin domain, so that FimH is nor-
mally auto-inhibited [5], as illustrated in Figure 2a.
True to the Greek origin of the word, which means ‘other
site’, the definition of allostery can be broadened to
describe any global conformational change in which an
‘other site’ regulates an active site because the confor-
mations of the two sites are structurally linked. By this
definition, the pilin domain is an allosteric inhibitor even
though it is part of the same peptide chain as the lectin
domain. When FimH binds mannose in the low-affinity
state, mechanical force applied across the bond could pull
the pilin domain away until it hangs by a thread, allowing
the lectin domain to snap tightly shut around the ligand in
the high-affinity state. Validating this idea, FimH in
fimbrial tips forms catch bonds that break mostly at
low force if pulled slowly, but at high force if pulled
quickly, or if pre-activated with mAb21, the A188D
interdomain point mutation, or even pre-stretching
[2!!], as illustrated in Figure 2b. This demonstrates that
mechanical force regulates FimH binding conformation
through control of allosteric conformational changes. This
general idea of mechanical regulation of active site func-
tion through allosteric-like regulation of a distal site is
termed mechanochemistry and is well accepted for motor
proteins.
It might be noted that every published FimH crystal
structure shows the lectin domain in the high-affinity
state due to truncation (e.g. [7]) or chaperone binding
(e.g. [8]). Thus, while biomechanical data demonstrates
that FimH forms catch bonds through an allosteric-like
regulation, the structural details of FimH mechanochem-
istry have remained unclear. However, new crystal struc-
tures of the low-affinity state show these structural
changes in detail (Thomas et al., unpublished data).
Structural and functional evidence of
mechanochemistry in selectins
The atomic nature of mechanochemistry has been best
demonstrated in selectins, which are a class of receptors
Mechanically activated bonds Thomas 51
Figure 1
Bond mechanics. (a) Without mechanical activation; slip bonds lifetimes as a function of force. (b) With mechanical activation; catch bond lifetimes as
a function of force. (c) Strength of slip bonds when force is increased until rupture. (d) Strength of catch bonds when force is increased until rupture.
www.sciencedirect.com Current Opinion in Structural Biology 2009, 19:50–55
Figure 11. Bond mechanics. In the absence of mechanical activation, the 
protein-protein interaction exhibit slip behavior as seen in (a), where the 
increase in force decreases bond lifetime. However, in the presence of 
mechanical activation, conformational change can lead to increase bond 
lifetime until reaching critical force as seen in (b). Further increase in force 
following critical force leads to a slip behavior. Adapted from [5]. 
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a slip regime where force shortens lifetime, presumably because further force overpowers 
the activated bonds (Figure 11) [5].  
 A Nikon inverted microscope (TiE) with 40X/0.75 objective lens and mounted 
with three micromanipulators: two pipettes (target and probe pipette) are opposing each 
other and one diagonally positioned facing the probe pipette.  
For the force-clamp assay, repeated cycles to measure lifetime under a specified 


















Figure 12. Force-clamp assay. T cell approached the bead to make an initial contact 
and was retracted to observe one of two things: (1) no adhesion, in which the signal 
leveled off to the point prior to the contact or (2) adhesion and clamped, in which the 
signal clamped to the set force and lifetime was recorded.  
 27 
approaches using the piezo actuator and impinges at a certain force (5-40 pN) on the bead 
adhered to the apex of the nystatin treated RBC, (2) the target cell/bead stays in contact 
for a set time period (0.1-2 sec) and is then retracted in which one of the two events takes 
place. A bond is not formed between the receptor and the ligand, resulting in the target 
cell/bead pipette to reset to its original position to begin the next cycle or a bond is 
detected at the force clamped signified by a tensile force, in which the lifetime is 
recorded until the survival of the bond ruptures (Figure 12). In some cases, adhesion 
takes place at set force, however, a stable lifetime does not prolong and stabilize, in 
which this particular profile is not considered for analysis. For the force-clamp assay, the 
RBC spring constant is set to 0.3 pN/nm and retraction speed set at 3 µm/s with loading 
rate 1000 pN/s. The entire cycle was repeated for 200 cycles and the binding frequency 
was kept at 20% binding frequency to ensure single pair of receptor-ligand interaction 
taking place. The force range used varied from 5 to 40 pN and lifetime data spread was 
binned 3 to 6 points to describe the bond-lifetime behavior. This was the sample mean for 
each bin and additionally, bootstrap method was performed to identify the magnitude of 
the fluctuations. Briefly, repeated samples are drawn (of the same size with replacement) 
from the data set at a large number of times providing a sample distribution from these 
repeated samples. 
3.2.5 Calcium Cell trap 
Using soft lithography, microfluidic cell trap devices were fabricated. Briefly, 
negative molds were initially fabricated using UV photolithographic process and 
patterned wafers were treated with T2492 vapor to prevent PDMS adhesion prior to the 
molding process. After adding PDMS to the mold and cured, molded PDMS was peeled 
and devices were used for experiments. For fluidic flow, medical grade polyethylene 
tubings were used and holes for these tubings were punched to fit 19 gauge needles. To 
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place the PDMS on an inverted microscope, the PDMS was bonded to a cover slip glass 
[60, 61]. 
3.2.6 Cell trap preparation 
Tubings connecting the outlet of the device was initially washed the inner tubing 
with sterile PBS. The microfluidic device was primed using the PBS and the device was 
checked under a microscope for any bubbles. Following thorough inspection of the 
device of the presence of any bubbles, 10 µl of biotin BSA was added through the inlet 
using 10 µl pipette tip. Flow into the device was accomplished by the pressure difference 
created by gravity from the placement of the tubing connected to the outlet. Device was 
washed with PBS and subsequently incubated with streptavidin similar to the step of 
Figure 13. Fluorescence cell-trap setup. Microfluidic cell trap placed at the 
microscope stage shown in red oval and placed nearby an air stream to maintain 
temperature at 37 ºC. 
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biotin BSA. The last step of functionalizing the device was done by incubating with the 
biotinylated protein of interest. 
Fluo-3 was incubated with the cells to detect calcium flux. After washing, upon 
which cells were loaded into the device and the device was positioned on the microscope 
stage. All experiments were performed under a temperature controlled environment 
(37°C) (Figure 13). 
3.2.7 Data Collection and Analysis from cell trap device 
Fluorescence microscopy was performed using a confocal microscope. Using 
Micro-Manager, an open source microscopy software, image acquisition with 
combination of time-lapse, multi-channel imaging, and z-stacks provided the experiment 
to be conducted following the events of the first cell viewed in the region of interest 
(ROI) and trapping [62]. Images from portion of the device over the duration of the 
experiment was sequentially captured. Custom Matlab® (MathWorks) GUI from Two-
Photon processor and SeNeCa [63] were modified to fit the experimental objectives for 
image processing. The entire process of user modification was minimized to provide 
consistency, reproducibility, and robustness by further modification done by the author of 
this dissertation. 
Briefly, images were cropped to reduce computational resources from the 
processing to contain only the portion of cell trapping of interest using ImageJ. The 
images captured displayed to have an uneven illumination from the light source. 
Therefore, as a first step towards analyzing, background correction to normalize the light 
intensity from the microscope across the image was performed. By varying multiple 
parameters, a mask is established for all the cells on the image of the traps. For each 
sequence of the image, the mask is established with individual cells labeled. Due to the 
cell mobility over the duration of the experiment, an additional parameter was set to track 
the cell from each image to ensure continuous observance of the fluorescence reading. 
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The program also has parameters to help discriminate single vs. multiple cells to ensure 
proper data collection. The objective of this method is to collect single cell calcium flux 
response by collecting the mean intensity of each ROI over time. Additionally, manual 
visualization of anomalies that the program accounts for were removed from the analysis. 
The normalized intensity for each object was determined by the ratio difference of the 
intensity after settling to the surface to the initial intensity at the point of contact on the 
surface of the trap.  
3.2.8 DNA Force Probe 
Custom synthesized oligonucleotides purified by Integrated DNA Technologies 
consisted of ssDNA hairpin hybridized through two 21-mer DNA handles to ligand and 
anchor strands. The ssDNA for solid support attachment on coverslips by commonly used 
chemistries. More specifically, modifications for oligonucleotide attachment was done by 
modifying 3’ amine-modified oligonucleotides covalently linked to succinimidyl 
glutaramide (SGA). The SGA is part of the maleimide-PEG-SGA linker, where the 
maleimide is reacted with the sulfhydryl of the 3-mercaptopropyl-trimethoxysilane 
(MPS) on the glass coverslip MPS coated surface. Maleimide-PEG-SGA forms a 
thioester bond that is covalently linked on the MPS surface of the coverslip. The 5’ end is 
modified with a biotin group to link biotinylated proteins by linking divalent streptavidin 
between the protein and the DNA force probe. The multiplexed tension probe surfaces on 
the coverslips were generated by having each hairpin sensor folded separately and then 
mixed with linker at various ratios followed by adding them to the MPS surface for 
overnight incubation [2, 64]. 
Following preparation of the functionalized coverslips, cells are added to the 
surface and allowed time to settle down to the surface (~5 mins) before conducting 
fluorescence microscopy.  
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The hairpin of the ssDNA contains a fluorescence resonance energy transfer 
(FRET) pair that consists of a quencher (acceptor) and a Cy5-QSY21(donor), which 
provided superior quenching efficiency. Live cells were imaged in 1X PBS at room 
temperature. For imaging, Zeiss LSM 710 NLO confocal microscope was used using a 
plan-apochromat 63X/1.4 oil immersion objective lens. The microscope was driven by 
the Zeiss Zen 2012 microscope and imaging software package, with the system including 
a fully automated precision stage, definite focus module without loss of focus. The LSM 
710 is equipped with a red 633 nm helium-neon laser for continuous spectral detection 
for detection and excitation of Cy5 fluorescence intensity, which closely matched dye 
configuration of Alexa Fluor 647 in the system. As Cy5 dye conjugated to the 
oligonucleotide strand is utilized in this study, cells initially sorted of anti-CD3 (clone 
UCHT1) conjugated to FITC and anti-CD8 (clone HIT8a) conjugated to PerCP-Cy5.5 
provided strong spectral overlap between PerCP-Cy5.5 and Cy5 dye. Therefore, anti-
CD8 of the same clone as previously stated was conjugated to Pacific BlueTM dye 
eliminated signal from the sorted cells. 
Following image acquisition at various parts of the functionalized areas of the 
coverslips, image was analyzed using ImageJ. Briefly, every cell (except morphologically 
apoptosis like cells displaying high number of granularity) in each snapshot were 
analyzed by drawing a circular ROI allowing to measure the intensity of the Cy5-dye 
fluorescence. An additional circular ROI of similar size to one of the cells was drawn on 
an open space of the same snapshot to obtain the background level intensity. Each 
circular ROI of the cells was normalized to the background of each image and the 
normalized intensity was obtained for each cell and the average was taken over all the 
snapshots of the particular condition. Cells displaying relatively increased normalized 
intensity (indicating separation of the quencher from the fluorophore) correlates with 
sufficient force (exceeding a threshold force) applied by the cell to unfold the hairpin and 
fluoresce (Figure 14). This depicts a molecular tension probe behaving as a switch 
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element reporting tension as a digital readout. The intensity from the reversible tension 
reporters is linearly proportional to the number of each receptor molecules exceeding a 
threshold force with the ligand on the surface depicted by each ligand linked probe 
engaging a single receptor. This is ideally suited for determining the force displayed by 
the cell mediated by the receptor/ligand interaction. The oligonucleotide’s nucleobase 
sequence at the hairpin provides the freedom to tune the force-response function by 
varying the number of sequences. 
b 
Figure 14. DNA force probe. (a) Schematic depicting DNA-force probe linked 
to an adhesive peptide and following adhesion, the unraveling of the hairpin 
structure to allow fluorescence to take place. (b) Representative image of cells 
bound to DNA-force probe fluorescing. (c) Variation of the A-T and G-C 
content influences the degree of forces required to open the hairpin structure. 
(a) Adapted from [1]. (c) Adapted from [2]. 
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3.2.9 in-vitro surface-bound pMHC T cell stimulation 
The technique utilizes the interactions of selective proteins and as a result, 
cytokine production of T cells will be observed. The assays employs T cell function 
readily following the interaction with the ligand to observe detection of cytokine 
synthesis, in this particular case IFN-γ, by intracellular cytokine staining (ICS). This 
assay will be performed by well-plate assay, in which protein of interest are surface-
bound coated. Using flat bottom well plates (48 or 96 tissue culture treated), biotin-BSA 
solution is initially covered by incubating the solution for 30 mins in incubator set at 
37°C and with 5% CO2. After washing the solution with PBS, streptavidin is then 
incubated similar to biotin-BSA. The last step involves incubating the biotinylated 
protein of interest either at the same time in the incubator or in 4°C overnight. After final 
washing with PBS, cells are added to the functionalized wells for 16-18hrs of stimulation. 
Followed by stimulation, cells are acquired for various staining including live/dead 
(L/D), surface protein markers and intracellular proteins, particularly ICS of IFN-g. L/D 
staining was analyzed using the APC-Cy7 channel, antibodies against CD3 was 
Figure 15. Schematic of reagent coating on well plate. A well plate zoomed into a 
particular schematic depiction of the protein coating with various reagents. Same coating 
reagents are used for microfluidic device. In the case of this study, the protein depicted 
on the image was substituted with biotinylated pMHC monomers. 
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fluorescein isothiocyanate (FITC) conjugated, for CD8 is peridinin chlorophyll protein 
complex (PerCP) -Cy5.5 conjugated and for IFN-g is allophycocyanin (APC) conjugated. 
Using Aria (BD), flow cytometry of the multi-fluoresce stained samples are acquired and 
analyzed by FlowJo software (Figure 15).  
3.3 Statistical analysis 
Conducted statistical tests employed the use of Student’s t-test or one-way 
ANOVA. Bootstrap was implemented to lifetime measurements of the force-clamp 
assays mostly due to limited number of observations and how we can estimate some 
quantity like the mean for the data set population from which the data was drawn. 
Thereby, by resampling with replacement from the data set, a population distribution can 
be simulated. We established 50 as the value of the number of bootstrap samples to be 
used in computation to obtain mean and the standard error of the mean. Box (3rd and 1st 
quartile for top and bottom with median in the middle) and whisker (maximum and 
minimum values for top and bottom) data was utilized for some of the data presentation. 
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CHAPTER 4 
KINETIC CHARACTERIZATION OF PP65 EPITOPE SEQUENCE 
VARIANTS TO HUMAN CYTOMEGALOVIRUS 
IMMUNODOMINANT CD8+ T CELLS 
 
4.1 Introduction 
Persistent viral infection such as EBV or herpes simplex virus utilize latent strategy 
to evade immune mediated cytolytic response. These viruses are expressed in low or 
moderate levels when presented by APCs and thereby, result in the survival for long-term 
due to corresponding low levels of CTL activation. Such mechanism is clear for their 
survival. However, not all viruses can adopt this strategy and therefore, induce an immune 
response that evidently leads to its clearance. However, viruses like HIV-1 and HCV adopt 
a different strategy that leads to their survival and that is by evolution. By mutations, these 
viruses adopt “survival of the fittest” strategy leading to an exhaustive state of the immune 
system, where no longer an immune repertoire can be generated or exists that can clear the 
infection. These mutations are sometimes a single alteration of the peptide sequence that 
leads to the failure of the CTL to respond. Yet, despite continuous exposure of CTLs in the 
repertoire, an effective response is failed to take place to eradicate the virus. Our objective 
is to understand how mutations influences the interaction that leads to disruption of a 
cytolytic activity. For such understanding, especially involving human and pertinent viral 
infections, it is difficult answering questions with experiment or mathematics alone. 
Therefore, the current disciplinary work for this study addresses these problems in the 
 36 
context of persistent viruses in human by utilizing CMV model and mutagenesis study to 
understand better of the interactions that leads to decreased viral immune response. 
  CMV adopts a strategy similar to EBV and it is characterized by low or intermittent 
levels of its own antigen expression resulting in low levels of CTL mediated activation. 
Therefore, CMV persists in the host and awaits an opportunity for the immune system to 
be compromised. CMV has evolved to take over the host immune system, remain latent 
and occasionally reactivate at which point 10% of the T cells population made up of CMV-
specific T cells counter the antigen presentation. The most dominant CMV viral peptide 
expression is the NLVPMVATV (NLV), which is the pp65 tegument protein found inside 
the capsid of the virus and this specific sequence is associated with the allele HLA-
A*02:01. Although error prone mutations do not occur frequently for CMV when 
compared to viruses such as HIV-1 and HCV, natural infrequent mutations have been 
reported (more specifically of the NLV peptide) and shown to impact cytolytic function of 
the CMV-specific T cells. In the case of HIV-1 and HCV, mutations lead to chronic 
development of the disease. Mutations of the viral peptides has been linked to impair CTL 
recognition and this is usually associated with amino acid substitutions that either leads to 
CTL mismatch with the peptide or alteration of the amino acid at anchoring residues to the 
MHC leads to the loss of peptide. As for the first case where a single amino acid 
substitution impacts CTL recognition and its function, how a single amino acid alteration 
influences TCR interaction is not fully understood. As such, the objective of this study is 
to understand how TCR interaction with WT and mutant peptides influence CTL function. 
Using biophysical assays, TCR-pMHC interaction can be characterized to better illustrate 
how the interaction influences CTL function. By using human PBMC known to be 
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positively identified with CMV infection and use NLV along with its variant peptides with 
mutations at known hotspots, a better understanding of CMV-specific T cell can become 
obsolete in its response and how viral mutation at key amino acids can potentially lead to 
viral escape and increase its viral fitness. 
Previous studies focused on characterizing biophysical parameters between TCR-
pMHC interaction of transgenic T cell system and have utilized this concept in the context 
of thymus T cell development understanding the role of peptides that are categorized either 
as positive and negative selecting ligands [65]. These studies have focused on linking 
kinetics parameters from 2D assays to predict the response of T cells and have highlighted 
the importance of how 2D kinetics fare better correlation with T cell response than 3D 
kinetics. The study has been extended to observe the role of force on TCR-pMHC bond 
interaction lifetime and how the bond profile regulates T cell function [66]. The importance 
from the previous studies has highlighted parameters that influence T cell response using 
transgenic mouse model system and therefore, it is one objective of this aim to extend the 
study to human viral infection using CMV system to better understand and stem the 
physiological relevance of the biophysical parameters. 
In the CMV model, the goal is to understand how immunodominant CMV-specific 
T cells that are enriched for recognizing NLV peptide interacts with both the WT and the 
its viral variants. The interaction between TCR-pMHC, like other receptor-ligand 
interaction, are constantly experiencing forces both from the environment and from cellular 
components that make up the membrane (i.e. lipid rafts) along with intracellular 
components like cytoskeletal components. It has also been shown before that the 
synchronous harmony from both the critical force and sufficient lifetime are crucial to 
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calcium flux [66]. As such, for the CMV model, these parameters will be analyzed along 
with binding kinetics to better understand how these parameters correlates and influence 
the functional outcome. In this study, we hypothesis that mutations of the viral peptide not 
only influence 2D affinity, but under tension force of the TCR-pMHC interaction disrupt 
sustainability of the optimal critical force and lifetime to effectively induce a proper T cell 
response. To provide a better definition of optimal T cell response in the context of human 
viral infection using human PBMC samples, the following aims are tested: 1) 2D 
biophysical assays provide higher sensitivity than 3D methodologies; 2) Characterize 2D 
affinities for activated polyclonal NLV-specific T cells to WT and variants from different 
donors; 3) Characterize application of native force experienced by T cell when interacting 
with the pMHCs used in the previous aim; 4) Characterize under a range of force and map 
the profiles for the interaction stated in the previous aims; 5) Evaluate functional response 
of activated NLV-specific CD8+ T cell to each of the pMHCs stated in the previous aims. 
Comparison of sensitivity to the 2D assay used to 3D assay was done by using 2D 
micropipette assay to conventionally used 3D staining method to measure the frequency of 
antigen specific T cells, tetramer staining. Development of tetrameric pMHC complexes 
has provided a snapshot view of peptide-specific CTL distribution. However, similar to 
another 3D methodology (surface plasmon resonance), sensitivity is limited to this 3D 
approach for detection. Our 2D approach used in this study to obtain 2D kinetic parameters 
resulted in higher sensitivity, even reporting detection and affinity not originally seen with 
one of the variants (T8V) [49]. 
Obtaining 2D affinities was achieved utilizing 2D micropipette adhesion frequency 
assay using human PMBCs that were pulsed with NLV peptide to enrich NLV-specific T 
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cells, and RBCs with various concentrations were covalently coated with biotinylated 
pMHCs. The effective 2D affinity of NLV-enriched CTLs to both WT and variants were 
measured from 3 different donors. Due to polyclonal nature of the system varying from 
donor to donor, the 2D effective affinity was within the same magnitude of order of all 3 
different donors. 
Using DNA-force probe technology allowed us to characterize the natural 
generation of force the T cells applied to pMHCs bound to DNA-tension force probes, 
designed to fluoresce if set force tension threshold can be sustained for the receptor-ligand 
interaction. We observed that activated NLV-specific T cells sustained bond interaction 
and strengthened bond interaction for two of the three pMHCs focused on this study. 
To characterize the force-lifetime profile under various clamped forces, BFP was utilized 
using the same CTLs as for the other assays, but the pMHC was covalently linked to 
streptavidin coated bead that was on a hypotonic induced RBC that was used as a force 
transducer with a known spring constant. All three peptides exhibited catch-slip bond 
profile and the lifetime at the critical force was measured for the three different donors. 
To understand the functional output following interaction with each of the pMHCs, we 
were interested in understanding the IFN-γ cytokine release. This cytokine has been linked 
to be released following CTL activation to block viral replication. To characterize this 
output purely from TCR-pMHC interaction, we used biotinylated pMHCs that are plate-
bound to initiate CTL activation and utilized ICS methods to obtain the frequency of cells 
exhibiting cytokine production. 
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Altogether, the approaches stated above provide a unique perspective and 
understanding of how viral variants utilize amino acid alteration to influence TCR 
recognition and influence functional outcome. 
4.2 Results 
4.2.1 2D biophysical assays provide improved sensitivity compared to 3D techniques 
To initially measure the frequency of NLV-specific CTL, NLV pulsed PBMCs 
were stained for CD3, CD8, and the NLV tetramer. From the lymphoycte gating placed, 
CD3 staining was split it into low and high CD3 levels based on two distinct populations 
observed. By gating the CD8 population for both the high and low CD3 expressing 
populations, two different populations of NLV tetramer frequency was observed. For the 
CD3high/CD8high population, not only a portion of NLV-specific CTLs were observed, 
there was almost >70% of the CD8 population that consisted of NLV-tetramer negative 
population. However, for the CD3low/CD8high population, >70% of the CD8 population 
consisted of NLV-tetramer positive population. It has been reported that activated CTLs 
downregulate CD3 expression [67] and that could be associated with the observation that 
higher frequency of NLV-specific CTLs were seen from the CD3low/CD8high population 
when the PBMCs were pulsed with NLV peptide. Since frequency of NLV-specific T 
cells was detected higher of the CD3low/CD8high population, frequency of cross-reactive 
or pMHC-specific tetramers were stained for the other viral variants were measured albeit 
at higher concentration for some due to affinity of the peptides (T8V, M5I, and P4FT8V). 
As for determining the sensitivity from the 2D micropipette adhesion frequency 
assay, we obtained the result from 40-100 CTLs that generated binding frequency greater 
than the background level. The background level of binding frequency was determined 
by using either streptavidin-alone coated RBCs or RBCs coated with a self A2 peptide. 
Binding adhesion was determined during the retraction phase of the RBC following 
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RBC/T cell contact and if the RBC adhered seen formation of tether when RBC was 
pulled back. Binding frequency was measured after 30 cycles of the following sequences 
that involved contact, impingement, and retraction. CTLs were sorted using tetramer 
stained sample as the template to sort either CD3low/CD8high or CD3high/CD8high 
population and the frequency of this assay was compared to that of tetramer stained 
sample. For CD3high/CD8high population, 2D assay displayed higher sensitivity than 3D 
tetramer (~3-fold increase). As for the CD3low/CD8high population, we observed similar 
sensitivity between the two assays for CTLs recognize NLV-MHC (Figure 16). Taken 
together these two findings illustrate that activated CTLs recognizing pulsed peptide in 
the form of MHC complex are similar, however, in the context of CD3high/CD8high, where 
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mixture of NLV specific and non-cognate specific T cells are mixed, the 2D assay prove 
to more sensitive than 3D detection.  
For the variants, only CD3low/CD8high population was analyzed for comparison. 
This is due to the technical limitation output if CD3high/CD8high population were sorted 
for 2D micropipette adhesion frequency assay as this sorted sample will have decreased 
proportions of selecting NLV-specific T cells to measure 2D affinity. Especially when 
measuring 2D affinities for variants that have very low binding propensity for majority of 
the polyclonal subset. When comparing the sensitivity of the CD3low/CD8high population 
from the two different assay across the viral variants, we observed that 2D assay has 






























































Figure 16. Comparison of antigen specific T cell frequency from Tetramer 
staining and 2D Micropipette assay. Comparison of high and low CD3 
population of NLV staining to 2D micropipette assay. Additionally, tetramer 
staining comparison to 2D assay for the different altered peptide ligands for 
CD3low/CD8high cells. 
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Overall, NLV-pulsed polyclonal T cells stained with tetramers of NLV and 
variant peptides to estimate the frequency of reactivity to the NLV and cross-reactivity to 
the variant peptides. As expected, NLV tetramer had the highest frequency compared to 
that of the mutants. Of the viral variants, T8V tetramer showed higher frequency of cross 
reactivity than M5I and P4FT8V. 
4.2.2 Disruption of molecular bonds impairs 2D effective binding affinity 
 In order to quantify the bimolecular interaction exhibited between the enriched 
CMV-specific T cells to that of the different pMHCs, we used 2D micropipette adhesion 
frequency assay (Figure 17). For the majority of the analysis, CD3low/CD8high population 
was analyzed due to enriched NLV-specific T cell observed from tetramer staining. 
Similar to the results of tetramer staining, 2D effective affinity of NLV peptide binding to 
CMV-specific T cells exhibited a log order higher than T8V peptide and two-log order 
higher than M5I and P4FT8V peptide. Both tetramer staining and 2D measurements 
indicate that mutations at the hydrophobic amino acid residue that directly contacts with 
the TCR has more profound impact on CMV-specific TCR recognition, more so than 
mutations at residue 8, where alteration of valine at this position to isoleucine resulted in 
disruption of hydrogen bond networks [49]. It is also observed that mutation at the 4th 
residue, another known hotspot [49] known for forming hydrogen bonds to a lesser extent 
than that of residue 8, from proline to phenylalanine of the T8V variant resulted in 
lowering the 2D affinity to the level of M5I variant. This double mutant was predicted by 
Paul Cardenas-Lizana in the purpose to identify the impact and the extent of the role the 
4th amino acid hydrogen bond contributes with the TCR affinity and later bond formation 
[49]. Clearly, the replacement to a bulky residue resulted disrupting its hydrogen bond, in 
addition to the hydrogen bond disruption at residue 8, resulted in lower affinity when 
compared to that of its single mutation counterpart.  
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The results shown in figure 17 shows the result of the 2D effective affinity from 
one individual donor (donor 9) and therefore, the measurement obtained most likely does 
not reflect as a universal number for all populations. Due to the possibility of donor to 
donor variations, we gathered two additional donors that are known to be CMV positive 
and set out to analyze their respective 2D effective affinity. What we observed from 
CD3low/CD8high populations of other two donors (donor 209 and donor 42) was that their 
2D affinity was statistically different from donor 9. However, all three donors had the 
same log order magnitude and the variation from different donors might rise from 
different clones with varied proportions, in which certain subsets of clone may exist in 
different frequencies between donors (Figure 18). 
 Additionally, we observed the two levels of CD3 population for analysis to 
determine if activated CTLs had differing 2D effective binding affinity than CTLs with 
higher expression of CD3. For the CD3low/CD8high population or the activated group, 2D 
effective binding affinity was 2.93x10-4 and in comparison to the CD3high/CD8high 
population, 2D effective binding affinity was 2.73x10-4 (Figure 19). This indicates that 

















Figure 17. Histogram of 2D effective affinity of pMHC to NLV-pulsed 
CD8+ T cells of Donor 9. Polyclonal NLV enriched, CD3low/CD8high sorted 
cells were measured for 2D effective binding affinity for the WT and mutant 
peptides. Table inset provides quantitative values of each peptide to the 
enriched polyclonal cells. 
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even after activation, the 2D effective binding affinity does not vary. However, there is 
always possibility using a higher coating of the NLV peptide could capture lower affinity 

























Figure 19. Binding affinity histogram of both CD3Low and CD3High populations. (a) 
Overlay of the range of affinities measured from CD3low (yellow bars) and CD3high 
(blue bars) population. (b) The cumulative data of the two populations. 
Figure 18. Measurement of 2D effective affinity of different donors. (A) 
Histogram of polyclonal enriched CD3low/CD8high binding to NLV-MHC. (B) Bar 
graph depicting the average 2D effective binding affinity among the three donors. 
Error bars represent the SEM. 








































4.2.3 Viral variants influence and disrupt bond lifetime interaction of NLV enriched 
CTLs 
 In order to understand how different hotspots of the peptide sequence influence 
bond lifetime under cell’s own endogenous force, sorted CD3low/CD8high cells were 
subjected to interact with the pMHC bound to DNA force probe designed to rupture at 
pulling force of 16pN. We chose 16pN DNA force probe to understand if tension can be 
prolonged to reach this level as we have previously reported from our OT-1 system to 
have reached this level force threshold to fluoresce and in another study, similar force 
level induced calcium flux [66]. Sorted cells were allowed to interact with pMHCs and if 
sufficient tension force threshold is met, the hairpin loop opens providing increased 
signal intensity indicating sustained increase in lifetime stemming from this interaction 
that reaches or exceeds the set threshold. Such was the case for the sorted cells interaction 
with NLV and M5I indicating TCR interaction with these peptides display prolonged 
increase in bond lifetime until reaching 16pN. However, sorted cells exhibited decreased 
intensity with T8V indicating that the bond lifetime between the interaction does not 
reach prolonged lifetime reaching towards 16pN (Figure 20). However, results from 
DNA force probe assay for both NLV and M5I indicates that the lifetime is prolonged 
towards reaching the critical force. 
























Figure 20. Histogram of DNA fluorescence probe intensity for varying 
pMHCs interaction with CD3low/CD8high population. Fluorescence intensity 
histogram of enriched polyclonal population of NLV pulsed PBMCs. 
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4.2.4 Characterizing bond lifetime under range of forces of various viral pMHCs of 
its interaction with NLV enriched CTLs 
 To fully elucidate the force-lifetime profile stemming from the DNA force probe 
assay results, we used biomembrane force probe to characterize over a long range of 
force lifetime profile. Initially we wanted to characterize at the critical force (set at 15 
pN) to understand the lifetime of the different pMHCs and from different donors. 
Comparing donor 9 with the other donors (donor 42 and 209), we observed that the 
lifetime of the WT pMHC to the sorted CD3low/CD8high samples was overall comparable, 
with the exception of donor 42, which statistically significant (Figure 21). As for the 
sorted sample binding to M5I-MHC, we did not observe any significant differences 
among the donors. However, interaction with T8V-MHC showed significance over the 
three donors. Altogether, the results indicate that the different donors have varied 
frequencies of clones that result in the varied lifetimes observed, this notion is 
emphasized especially with interaction with T8V-MHC. Additionally, we observed that 
the alteration at the 8th residue, where the dense hydrogen bond network is disrupted, 
collectively among the three donors depicts lifetime is not sustained for long duration as 
compared to the interaction with M5I-MHC, where the hydrophobic interaction is Critical Force peptide mt MHC





















Figure 21. Comparison of critical force bond lifetime of different donors of 
different peptides. Clamp force at 15pN to characterize bond lifetime of 
different donors to the WT and the single mutant. 
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disrupted. This is surprising when comparing these results to that of the 2D affinity, 
where T8V group showed a log order higher than that of the M5I. 
As such, we next characterized the lifetime profile over range of forces to 
categorize the bond profile and we selected donor 9 samples to characterize due to its 
abundance of NLV-specific T cell frequency from tetramer staining. TCR binding to 
NLV-MHC displayed catch-slip profile, with critical force situated at 15pN with lifetime 
2.6 sec. In the case for M5I interaction with the CMV-specific T cells, we observed 
lifetime being prolonged at similar critical force (Figure 22). However, the lifetime 
duration is significantly lowered for this particular interaction at the critical force 
resulting from the disruption of the hydrophobic interaction. This once again, implies, the 
hydrophobic interaction from methionine contributes in strengthening the bond and 
potentially plays an essential role in propagating signal transduction. 
 The effect of disrupting the hydrogen bond network resulted in the critical force 
reaching well below the threshold for M5I and NLV (Figure 22). Based on this effect on 
lifetime following mutation at the 8th residue to valine, which is a smaller amino acid in 

















Figure 22. Bond mechanics profile of donor 9 samples to the various 
peptides. Sorted polyclonal NLV-specific T cells interaction with the 
various peptides under different force clamps was characterized. 
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length than threonine, we can potentially link this result of the effect of threonine on 
forming new hydrogen bonds as the force is increased. 
Lastly, we measured an additional alteration of an amino acid to a previously 
mutated peptide (T8V), the resulting double mutation, P4FT8V. The hypothesis, based on 
molecular dynamic simulation performed by Paul Cardenas-Lizana, was to understand if 
this particular mutation can help shift the critical force to the level of NLV- and M5I-
MHC. By mutation to phenylalanine from proline, the hypothesis is to further enhance 
the effect of hydrogen bond formation of proline by introducing a longer amino acid, 
such as phenylalanine. This result of the double mutation impacted the critical force to be 
shifted to the level of both NLV and M5I. However, due to disruption of the hydrogen 
bond network at residue 8, no additional hydrogen bonds are formed preventing increase 
in lifetime to the level of the NLV-MHC. 
In summary, key hotspots in the peptide sequence contribute both in stability and 
prolonging lifetime under force. Both are critical components in influencing signal 
propagation through the TCR for the CTL to effectively induce cytolytic response to the 
viral infection. 
4.2.5 Cytokine production response to interaction with various viral pMHCs 
Many system shows that stimulation with tetramer alone does not stimulate 
cytokine release, although the addition of exogenous peptide and co-stimulation produces 
a strong response. Here we show that surface bound pMHC can stimulate NLV specific T 
cell to generate cytokine secretion. In order to understand the functional response stemming 
from CMV-specific T cells interaction with NLV and the mutant variant pMHCs, we 
evaluated the production frequency of IFN-g of CMV-specific T cells via ICS (Figure 23). 
ICS was conducted following incubation of the entire pulsed PBMCs on plate wells coated 
with respective pMHCs at various concentrations. After overnight stimulation, CMV-
specific T cells incubated with NLV-MHC had the highest production of IFN-g at very low 
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concentrations (especially 0.01 µg/ml) in comparison to the other variants. Mutant variant 
T8V displayed the second highest production of IFN-g, albeit at very high concentrations 
to get similar IFN-γ frequency as the NLV-MHC (10 µg/ml of T8V-MHC vs. 0.1 µg/ml) 
By comparison, mutant variant M5I had the least production of IFN-g among the different 
pMHCs. To obtain similar frequency of cells generating IFN-g as the NLV-MHC, 10 µg/ml 
of the variant is used to get approximately 10% frequency, which was achieved using the 
NLV-MHC at a concentration of 0.01 µg/ml. Altogether, these results indicate that the 
hydrophobic residue methionine plays a central role in recognition and function and its 
disruption significantly influence an effective response.  
4.3 Discussion  
The immune system of a host initiates a massive polyclonal T cell response 
following viral infection, however the specificities of only a small percentage of these 
activated cells are known in various diseases and they are usually the immunodominant 
subtypes. In the case of  CMV infection for humans with HLA-A*02:01, immunodominant 
restricted epitope derived from CMV protein is NLV specificity during steady state and 





























Figure 23. Intracellular cytokine staining of antigen specific T cell from surface 
coated pMHC stimulation.  Percent of CD8+ T cells that secretes IFN-γ from entire 
CD3 and CD8 population. Positive control used here is PMA/Ionomycin and the 
negative control is an irrelevant pMHC sharing similar allel as the cognate pMHC. 

























































pathological situations associated with CMV reactivation [68]. A large fraction of NLV-
specific T cells derived from numerous individuals expressed a “public” TCR feature that 
exhibited full conservation of the TCRα chain junctional region, however, TCRβ chain 
junctional region varied and highly diverse. At low detection limit, 2D micropipette has a 
higher sensitivity detecting antigen specific T cells than tetramer staining. Upon 
reactivation of CMV-specific T cells, a clonal focusing takes place where public TCR 
clonotypes exhibiting high affinity for the antigen dominates, implying that TCR affinity 
plays a central role in repertoire focusing. To mimic this phenomenon, in vitro stimulation 
with NLV peptide increase the frequency of dominant private NLV specific T cells from 
various CMV-positive donors to understand the kinetic interactions of these polyclonal T 
cells to WT peptide and epitope variants. This provides a true understanding of how varied 
the 2D effective affinity from a given individual highlighting the variation and the average 
parameter from a donor. 
Unlike HCV, CMV infection typically do not constitute mutations stemming from 
HCV inherent RNA-dependent RNA error-prone polymerase. Therefore, CMV mutations, 
if occurring, is exerted by selection pressure from the environment or by drug selection. 
Immune response mediated selection pressure has been a mechanism to cause sequence 
variability and immune escape for both viral infection, tumor and autoimmunity [50]. To 
understand the principles of a polyclonal T cell response interaction with WT and its 
variants, this study focuses on an infrequent naturally occurring mutation of the NLV 
peptide and a synthetic mutation to understand how amino acid substitutions at non-
anchoring residues influences biophysical and functional analyses. 
The tetrameric assay has influenced our knowledge of human disease and has 
provided insights into the frequency, phenotype, and functions of CD8+ T cells, especially 
in the case of viral infections. Alongside, 3D assays like biacore, has provided kinetic 
parameter using purified TCRs. Both these assays lack sensitivity and particularly biacore 
experiments can utilize a single TCR at a time. Due to clonal diversity of T cells found 
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within a host, it is imperative to address the kinetics on average and additionally, 
characterize the effective cross-reactivity with altered-peptide ligands. 
To understand how T cell viral reactivity relates to 2D binding parameters and to 
directly compare them, kinetic analyses was performed of a panel of viral antigens to a 
polyclonal enriched NLV-specific T cells. Panel of viral epitopes utilizes the WT and its 
variants. Mutation at the 5th residue from methionine to isoleucine has previously shown 
to result in a decreased lytic function [50]. Methionine plays an important role in forming 
a hydrophobic interaction with the immunodominant public NLV-specific T cells and it 
has been identified as a hotspot in the amino acid sequence of the NLV epitope [49].  
Mutation at this residue provides insight that methionine plays a central role in establishing 
a stable bond between the TCR and the pMHC. Additional hotspots in the NLV peptide 
sequence are at the 4th and 8th residue, however, of the two, threonine at the 8th residue 
forms a network of hydrogen bonds with the TCR and thus, we predicted that this residue 
plays a central role in formation of new bonds that strengthen the lifetime as force increases 
between the TCR and pMHC [49]. Our results show us that, by mutation of this residue 
from threonine to valine, we observed the catch bond formation was capped off before 
reaching the critical force observed with the WT peptide interaction. 
The effective 2D affinity correlates positively with the functional response. By 
focusing on the lifetime measurement at the critical force (15 pN) of donor 9, the functional 
response correlates with the duration of the lifetime, as well. This might imply that 
although affinity is an important component of signaling that has been well characterized 
to correlate with function, the force induced bond-lifetime results indicate that increased 
lifetime at critical force also correlates with increased functionality. However, when 
considering all the parameters, 2D effective binding affinity threshold has to be met 
followed by the duration of the lifetime to induce the proper cytokine function as suggested 
by the data. 
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Application of force provides more insight on the TCR/pMHC interaction 
providing potential mechanisms viral mutations could influence binding kinetics and how 
that translates to impacting functional response of the CTL. Mutations at hotspots that 
contributes heavily in bond formations impacts the profile differently depending on the 
peptide and its alteration. Ultimately, viral mutations take place to evade immune response 
and help facilitate the survival of the virus. Current conventional methodologies (3D 
assays) provide basic kinetic parameters to understand the propensity of the binding. By 
utilizing 2D assays, especially understanding how force-clamping impacts bond survival 
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After viral clearance, an essential component of the immune response, contraction 
of the host’s adaptive immune cells takes place setting up a repertoire moving forward to 
combat upcoming secondary infection. However, during and following viral clearance, the 
environment is modified in which the cells reside and cells from different environment can 
influence their behavior and function. However, how this occurs and what triggers their 
modulation has not been fully elucidated. To understand how viral infection influences 
shaping the immune cells, LCMV mouse model infection is utilized, as well as, adoptive 
transfer method of viral-specific monoclonal transgenic cells to track and conduct ex-vivo 
studies. Primary focus on T cell are from those residing in spleen, as it mostly known here 
to play a prominent role in facilitating induction of an adaptive immune response. Close 
inspection of the anatomy of the spleen shows two distinct structures: WP and RP. Blood 
enters the spleen through the marginal sinus and travels through the RP away from the WP 
to return back to the vasculature network via venous sinuses. At the border of marginal 
sinus and WP, APCs capture pathogens and within the WP, initiate productive contact with 
their cognate lymphocytes and provide signals within this niches to initiate differentiation 
to CTLs [44]. 
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As spleen contains two functionally and morphologically distinct compartments, 
the goal of this study is to understand the kinetics of viral-specific T cells, specifically 
adoptively transferred P14 cells that is cognate T cell recognizing LCMV infection, from 
these compartments over the course of the infection. Additionally, correlate the functional 
effect of cells residing in their respective compartments. In the process of this immune 
response, an additional goal is to elucidate the mechanism that contributes to the effect 
observed. 
5.2 Results 
5.2.1 Localization within anatomical compartmentalization of CD8+ T cells exhibit 
differential TCR-pMHC interaction during early immune contraction phase 
To understand the kinetics of CD8+ T cell undergoing the influence of viral 
immune response, naïve mouse was adoptively transferred with P14 cells and infected with 
LCMV Armstrong infection to induce an acute viral immune response. Following days 
after infection, adoptively transferred P14 cells were sorted out from their respective 
compartment (i.e., WP or RP) and were subjected to measuring 2D binding affinity. 
Adoptively transferred P14 cells to host without infection was also conducted to observe 
how naïve P14 cells 2D kinetics fared from respective compartments. To determine the 2D 
affinity of the P14 TCR from each respective compartment, RBCs coated with biotinylated 
gp33-43 (gp33) was utilized as a surrogate APC. The H2-Db MHC was mutated in most cases 
to focus on the bimolecular interaction between TCR and pMHC. The 2D effective affinity 
was measured from each compartment during the three main phases of the immune 
response: naïve, effector, contraction and memory phase of the T cell differentiation. 
Monoclonal P14 T cells exhibited modulation in 2D TCR affinity over the course 
of the immune response both in the WP and RP. More evidently, 2D TCR affinity of RP 
P14 T cells during early contraction phase (9 and 11 dpi) exhibited markedly higher than 
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P14 T cells from WP (Figure 24A). Furthermore, use of gp33-tetramer staining resulted 
indistinguishable between the two compartments, consistent with the previous aim and 
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discriminate TCR-pMHC interaction (Figure 24G) [69, 70]. Keeping the comparison 
between the two compartments, P14 T cells from WP and RP exhibited comparable 2D  
effective binding affinity during day 0 (naïve), 7 (effector), and 31 (memory) post infection 
along with other additional days (Figure 24A).  
Additionally, following adoptive transfer of P14 cells and infection, endogenous 
LCMV specific T cells recognizing a different epitope from gp33 was also assessed at 11 
dpi. By coating RBCs with NP396-404-MHC, cells sorted from RP and WP were measured 
for their respective 2D effective affinity, which in result displayed RP cells exhibiting 
higher 2D effective affinity than WP (Figure 24B). The possibility of a second TCRα chain 
in TCR-pMHC interaction could potentially be one reason of the enhanced 2D affinity 
observed in RP. To test this notion, recombination activation gene (RAG)-1-deficient P14 
was adoptively transferred and after 11dpi, 2D effective affinity was assessed from their 
respective compartments. The results of adoptively transferred RAG-1-deficient P14 cells 
also exhibited similar differences in 2D effective affinity from respective compartments 
similar to that of the wild-type P14 cells (Figure 24C).  
Figure 24. TCR–pMHC interaction of LCMV specific T cells from the WP 
(blue) or RP (red) measured at the indicated dpi. (A) The red line depicts the 2D 
effective binding affinity of adoptively transferred P14 cells sorted from the RP, 
whereas the blue line depicts P14 cells from WP. Cells binding to gp33-MHC 
utilizes a mutated MHC preventing binding between CD8 and MHC. (B) 
Endogenous NP396-specific T cells sorted from their respective compartments were 
measured of their 2D effective binding affinity at 11dpi; the mouse was also 
adoptively transferred of P14 cells. (C) P14 T cells that are of RAG-1-deficient were 
adoptively transferred and following 11dpi, transferred cells from their respective 
compartments was analyzed for their Acka. (D) Average number of bonds 
normalized to the pMHC density comparison of P14 T cells to gp33 pMHC, 
trimolecular interaction involving TCR-CD8-pMHC. (E) Adoptively transferred P14 
T cells binding to non-cognate peptide MHC to evaluate the binding between CD8 
and MHC H2-Db allele at 11dpi. (F) Comparison of P14 T cells binding to gp33 
mutant MHC from respective compartments to that of P14 T cells binding to anti-
TCR antibody. (G) Comparison of sorted P14 from respective compartments by 
tetramer staining. 
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 In most experiments for the LCMV study, peptide is complexed with a mutated 
MHC, thereby eliminating the interaction between MHC and CD8. However, when 
measured using gp33 complexed with wild-type MHC against P14 T cells, involving tri-
molecular TCR-CD8-pMHC interaction to take place, the average number of bonds 
normalized to the pMHC density differed as well between the two compartments (>7 fold 
shown in Figure 24D). Therefore, to investigate whether CD8 interaction alone with MHC 
exhibited similar observation, P14 cells were subjected to interact with NP276-286 
complexed with wild-type MHC capable of forming CD8 interaction, but not with the P14 
TCR. This resulted in the differences being abolished between the two compartments 
indicating the differences observed were TCR-pMHC mediated (Figure 24E). To 
understand if TCR binding to other proteins, such as anti-TCR antibody, exhibited such 
differences, RBCs were coated with anti-TCR antibody. The result of this interaction also 
abolished the differences observed between TCR-pMHC from respective compartments 
(Figure 24F).  














Figure 25. Force-clamp lifetime measurement of compartmentalized P14 cells 
following 11dpi. P14 cells sorted based on localization in RP or WP were 
characterized for their lifetime. Bootstrap implementation of lifetime measured at 
each force clamp. 
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Being that gp33-MHC is a agonistic peptide for P14 T cells, the interaction between 
the receptor-ligand was evaluated for its bond mechanics under force and how the 
interaction is regulated due to the compartments they reside (Figure 25). Following 11dpi, 
sorted P14 cells from their respective compartments exhibited catch-slip behavior. 
Interestingly, cells from both compartments exhibited a catch behavior at an early force. 
The differences, however, was clearly seen when addressing the lifetime duration 
parameter. RP P14 cells exhibit longer bond lifetime than that of the WP P14 cells. 
5.2.2 Local vs. systemic environmental effect on the enhancement of the 2D effective 
affinity of CD8+ T cells to recognize potentially minute levels of antigens and viral 
escape variant 
The RP compartment consists of blood-filled sinuses and play a distinct role in 
filtering RBCs. Additionally, being that the RP of the spleen is connected to the vasculature 
network of the host transporting cells from one organ to other sites, we also investigated 
the 2D effective affinity of antigen-specific cells found in peripheral blood to compare the 
kinetics observed within the two compartments of the spleen. At the height of the immune 
response (7dpi) and at 15dpi, P14 cells from peripheral blood exhibited similar 2D effective 
binding affinity as those of the cells from the respective spleen compartments. However, 
at 11dpi, P14 cells from peripheral blood exhibited the high 2D effective affinity just as 
P14 cells as the cells from RP, potentially depicting the notion that the increased enhanced 
recognition by P14 cells in circulation might be associated with targeting minute residual 
antigen presentation of the viremia (Figure 26a). The survival of viruses is dependent on 
the effectiveness of the immune recognition and if effective, viruses could be forced to 
mutate to evade immune response. If such scenario were to take place, the enhanced 2D 
effective affinity during early contraction from RP could facilitate recognizing escape viral 
variants with heightened sensitivity. To test this notion, a mutant of gp33 was used to 
observe how the viral variant impacts P14 cell recognition from each respective 
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compartment derived from the spleen. One previously observed natural viral variant of 
gp33 is gp35A (V35A), where at the 35th residue valine was substituted with alanine [47, 
71]. Although P14 cells from both RP and WP exhibited lower 2D effective affinity for 
V35A when compared to that of gp33 following 11dpi, the differences between the RP and 
WP still held true, as RP displayed higher 2D effective affinity than WP when recognizing 
the viral variant V35A (Figure 26b).  
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Figure 26. Kinetics of P14 T cells outside the local environment 
and recognition to mutation. (A) Adoptively transferred P14 T cells 
from peripheral blood exhibit similar kinetics to RP T cells and not 
WP from their respective days. (B) Adoptively transferred P14 T cells 
recognition to mutant peptide exhibit higher 2D effective binding 
affinity of populations from RP than WP following 11dpi.  
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5.2.3 Functional response of compartmentalized P14 T cells following recognition of 
cognate pMHC  
As for the functional relevance of P14 T cells stemming from different 
compartments, following 11dpi, RP P14 cells exhibited increased calcium flux when 
compared to that of cells from WP (Figure 27 a and b). This supports the idea that P14 
cells from RP are capable of efficiently targeting cells and signaling for lysis than cells 
from WP. Furthermore, RP P14 cells have higher proliferative capability following 
interaction with gp33-MHC than P14 cells from WP following 11dpi utilizing plate-bound 
pMHC stimulation (Figure 28c). Altogether bringing 2D effective affinity data and 
functional outcome following 11dpi, P14 T cells from RP exhibited higher 2D effective 
affinity than WP P14 T cells. This correlates with increased calcium signaling potentially 
for killing and proliferative capability.  
5.2.4 Anatomical compartment effect on WP CD8+ T cells by cellular and protein 
regulators  
As the spleen is composed of different cells particularly residing in certain 
compartments, these cells that make up the compartments could potentially influence 
antigen-specific T cells to be mediated by direct contact or through cytokine release in the 
local microenvironment. The RP and WP are not only functionally and structurally 
distinctive, but as well as the cellular composition that make of it. Close inspection of the 
WP reveals an abundant level of CD4+ T cells, which facilitate the priming of CD8α+ DC 
and in result priming of CD8+ T cell activation. In comparison, DC also make up the 
composition of RP, however, circulating CD8+ T cells are found in higher frequency 
following the induction of the immune response and are frequently gaining access to 
secondary lymphoid organs in search for cognate antigens [45, 72]. Due to the presence of 
CD4+ T cells in the WP having more pronounced contact with the CD8+ T cells, ablation 

























































































cells following 11dpi (Figure 28a). The result of this conditioning dramatically increased 
the 2D effective affinity of the WP P14 cells to the level of RP P14 cells. Furthermore, 
CD4+FoxP3+ regulatory T cells (Tregs) play an important in downplaying the effector 
function of CD8+ T cells and with this rationale, ablation of Tregs were undertaken (Figure 
28b). Specifically removing Tregs resulted in the dramatic increase of the 2D effective 
affinity of P14 cells from WP similar to the values observed of T cells from RP.  
Tregs plan an important role in regulation of immune response mediated either 
through direct contact or via protein secretion and that can potentially have an impact 
regulating the 2D effective affinity of CD8+ T cells found in the WP. To address whether 
transforming growth factor (TGF-β) secretion, an influential cytokine known to play 
pleiotropic role in the control of T cell immune response  [73] and modulation of Treg 
function [74], blocking of TGF-β using specific inhibitor (SB431542) in mice and 
subsequently measuring kinetics of P14 cells from respective compartments was conducted 
(Figure 28c). This resulted in observation of no differences seen between the P14 cells 
from WP and the RP, as the P14 cells from WP had an elevated 2D effective affinity similar 
to that of the P14 cells found in RP. Additionally, in vitro treatment of RP P14 cells 
following 11 dpi exhibited lower 2D effective affinity when compared to no treatment. 
Similarly treated 7 dpi RP P14 cells did not lower the 2D effective affinity when compared 
to that of 7 dpi RP P14 cells with no in vitro conditioning.  
Figure 27. Compartmentalized P14 T cells response to antigen recognition. (A) 
The average fluorescence intensity of the cells analyzed in (B). Cells loaded with 
Fluo3-AM cytoplasmic calcium indicator. (B) Heat map for individual P14 cell 
response from respective compartments to peptide recognition over a course of the 
time period. Colors indicate low (blue) to high (red) cytoplasmic calcium indicators. 
(C) Respective compartments of adoptively transferred P14 T cells following 11dpi 
were incubated with CFSE dye and placed in wells coated with gp33-MHC and 
observed using flow cytometry following 3-day incubation. 
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5.2.5 in vitro conditioning of anatomic compartmentalization CD8+ T cells regulating 
2D effective affinity during early immune contraction phase 
Understanding the effects stemming from Tregs and TGF-β, rather than separately 
done so from the in vivo experiments, in vitro experiment involving incubation with Tregs 
and blocking antibodies targeting TGF-β were conducted. Incubation of RP P14 cells 
following 10dpi along with Tregs in the presence and absence of TGF-β for 24 hrs provided 
a more in-depth interconnection of the two composition on the effect on 2D effective 
affinity (Figure 29). As observed by the in vivo experiment involving ablation of the Treg, 
incubation of Treg with RP decreased the 2D effective affinity, while blocking TGF-β 
alongside with Treg did not impact the 2D effective affinity compared to that of the no 



























































































TGF-b inhibitor 11dpi 
Figure 28. Localized components regulates P14 T cells. (A) Ablation of CD4+ T 
cells by GK 1.5 antibody to mice infected with LCMV abolished the differences 
between the P14 cells from different compartments 11dpi. (B) Similarly, 
adoptively transferred P14 T cells into FoxP3-DTR mice also exhibited no 
differences between the two compartments by removal of FoxP3+ cells from the 
host. (C) TGF-β inhibitory drug treatment to mice infected with LCMV also 
abolished differences seen when compared to that of the untreated mice. 
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the 2D effective affinity for antigen-specific T cells found in WP during the early 
contraction phase of the immune response.  
5.2.6 Post-translational modification and membrane organizing effect on 
anatomically compartmentalized CD8+ T cells  
Cytokine influence has been shown to cause post-translational modification, 
especially regulating plasma membrane clustering [75]. As such, P14 T cells were 
subjected to in vitro treatment focused on cluster membrane organization. Cells sorted from 
RP and WP were treated with nystatin to sequester lipid raft or treated with cholesterol 
oxidase to remove cholesterol (Figure 30 a and b). Thereby, such treatments following 
TCR interaction will prevent  formation of cluster to take place and observe the effect on 
their respective 2D effective affinities. Following such post-translational modification, we 
observed that no differences were observed between P14 cells from RP and WP. 
Interestingly, the treatment of RP cells decreased the 2D effective affinity when compared 
to that of the no treatment done to RP P14 cells. To rule out other post-translational 
modifications, P14 T cells were subjected to deglycosylation by PNgase F treatment was 


























































Figure 29. in vitro conditioning of RP P14. Following 10dpi, P14 cells were 
conditioned with various components to understand the role of each components 
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to that of the untreated. Altogether, release of TGF-β by Tregs could poetntially inhibit 
lipid raft formation, thereby inhibiting increased 2D effective affinity, a mechanism 
potentially inherent to prevent excessive damage to the surrounding tissue. 
5.2.7 Cluster-induced 2D binding affinity of memory marker specific T cells 
Further investigation into the type of T cells that are exhibiting increased 2D 
effective affinities, P14 following 11 dpi were sorted based on memory markers to 
understand the role of various subsets of antigen experienced cells respective to their 
anatomical location. Early effector (KLRG1high/CD127low; SLEC) and memory 
(KLRG1low/CD127high; MPEC) precursor marker cells from both WP and RP were sorted 
to understand how the anatomical location of these subsets of cells influence their binding 
kinetics (Figure 31). Cells sorted based on memory markers from RP had two differing 
2D effective affinities populations, specifically, SLECs display increased 2D effective 
affinity when compared to that of the MPECs from the same compartment. However, the 




































































































A LR Depletion Deglycosylation 
Figure 30. Post-translation modification treatment on P14 T cells. (A and B) 
P14 T cells were treated with membrane disrupting drug to inhibit the effect lipid 
raft cluster formation of sorted samples following 11dpi. Following treatment, both 
conditions exhibit a decreased 2D effective binding affinity. (C) Sorted P14 cells 
following 11dpi were deglycosylated and did not affect the 2D effective binding 
affinity. 
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subset of cells found in RP. The population pertaining to the SLEC markers did not exhibit 
a higher 2D effective affinity when compared to that of the MPECs found in WP.  
5.3 Discussion 
Host immune response to viral infection induces a T cell activation of cognate 
specific T cells for expansion to efficiently recognize to clear viral infection. An 
increased frequency of high affinity subset of clones provides effective clearance of the 
virus, particularly in the case when viral mutations occurring to escape from the CD8+ T 
cell response. Indeed, occurrence of viral escape mutants take place during the 
contraction phase of the immune response, following the peak of viremia [76]. The 
precise timing of generation of viral mutations indicate the cost of viral fitness, and 
coincidentally, an increased 2D effective binding affinity from RP and the vasculature 









































 = Memory Precursor (MP) T cells 
Figure 31. Memory marker specific T cells role in 2D kinetics. P14 cells sorted 
based on anatomically localized compartments and on memory markers expression 
following 11dpi. 
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phase, the increase in 2D recognition provides insight on development of novel strategies 
to combat persistent viral infections. 
Conventionally, when analyzing cells in organs, many studies rely on the entirety 
of the organ rather than segregating the compartments based on the anatomy of the organ 
(tissue embedded vs. circulating). Therefore, it is important to dissect where, when, and 
how viral specific T cells respond within the spleen. By allowing to analyze cells from 
compartments provides insight on how the microenvironment influences major leukocyte 
markers, kinetics and activity that might otherwise conflate interpretation of between 
localization vs. the organ itself. Regardless of the memory markers, what was observed 
using 2D assay is that phenotypic markers alone do not exhibit certain activity, as the 
anatomical localization of the cells within the organ, in addition to phenotypic markers, 
regulate cellular kinetics. Furthermore, cellular and protein compositions that constitutes 
the localized site regulates TCR-pMHC interaction, suggesting these compositions found 
particularly in WP plays a central role in establishing long-term memory subsets. 
Whereas in the absence of these compositions, expanded CD8+ T cells are short lived in 
the periphery. Regulation of cellular and protein components, such as TGF-β and Treg, 
has influences CD8+ T cell response in many diseases and influences [77-80]. 
Additionally, cytokines have shown to influence post-translation modification of protein 
to regulate cellular trafficking [81]. Post-translation modification, including cholesterol 
membrane clustering of TCR, has been influential in signaling for T cells [82-87]. As 
such, local compositions that are compartmentalized can regulate membrane cholesterol 
level in regulating TCR-pMHC interaction that can implicate the outcome of various 
diseases. T-cells from spleen was sorted based on compartments and then by marker 
expression within their respective compartment. Marker expression on cells were used 
sorted to the following subsets: SLECs and MPECs, which is capable of generating long-
lived memory CD8+ T cells (central and effector memory T cells) [8]. 
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As MPECs found in WP are continuously interacting with antigen, this provides 
an environment to potentially downregulating their effector functions due to immune 
regulating compositions in WP and when SLECs or effector cells from RP enter into WP, 
the continuous interaction with antigen could eventually lead to functional exhaustion 
due to heightened 2D effective binding affinity [88]. Because of high rate of interaction 
with antigen in WP than in RP, both MPEC and SLEC found in WP behave the same. 
Over the course of acute infection, MPECs found in RP are driven towards 
differentiating to SLECs or effector cells due to repetitive antigenic interactions in 
peripheral sites (but not continuously as would be in the case in WP) [88] and some 
MPECs just entering into RP from the WP, which could be the reason for the 
heterogeneous population in RP being observed. It is also shown through 2D 
measurement that SLECs in RP have higher affinity than MPECs found in RP. These 
results highlight that intricate regulation of T cell function and fate is determined by 
anatomic compartmentalization during the early immune contraction phase. 
In summary, this study has shown that anatomical compartmentalization of CD8+ 
T cells plays an important role in establishing the lineage and activity of the cell, 
especially their recognition. Interestingly, during early contraction phase of the immune 
response, peripheral CD8+ T cell experiences an increased sensitivity to recognize minute 
antigen levels and mutant viral epitopes to prevent persistent infection to take place. 
These results provide insights and implications in developing novel approaches to 




CONCLUSIONS AND FUTURE DIRECTIONS 
 
 The thesis on analyzing kinetic parameters on CTL in the context of viral 
infection encompasses utilizing biophysical assays to understand the interaction between 
TCR and pMHC. Firstly, we demonstrated how private dominant polyclonal antigen-
specific T cell interacts with both the WT and variants by using CMV model and we have 
shown that sensitivity with 2D biophysical assays provides binding kinetics and insight 
far better than 3D conventional assays [49]. Provided these cells are experiencing force 
from its environment, we have shown how the interaction (bond lifetime) between the 
TCR and pMHC (both WT and variants) are influenced under various force clamps. 
Unlike integrins, which exists in multiple states, associates with various lifetime events 
that can be addressed as a two-state model [89]. However, no known multiple states of 
TCR has been shown, yet we observed two state fit for the survival frequency for 
polyclonal enriched NLV-specific T cells binding to NLV peptide using mutant MHC, 
which abolishes CD8 binding to MHC (Figure 32). Interestingly, this two state fitting 
exhibited only at the non-critical force, and at the critical force a single state fit was 
achieved. This could potentially imply that mobility might exist of the peptide in the 























































Figure 32. Analysis of lifetime bonds of TCR-pMHC of CMV polyclonal cells. Plots 
of survival frequency versus lifetime data and the two-state fitting (solid red line). 
Lifetime distribution from critical force, force clamped higher than critical force, and 
force clamped lower than critical force. 
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when the peptide interfaces with TCR [90]. This mobility that exists between the two 
proteins could potentially be stabilized at the critical force, which could imply the most 
optimal state to induce signaling to the T cell. 
 Characterizing kinetic parameters of the CMV has established a ground work on 
understanding polyclonal T cell interaction with both WT and mutant variants. However, 
we utilized certain mutants to understand the importance of various interaction between 
TCR and pMHC. In the case of HCV, hydrogen bonds between pMHC and TCR has 
been highlighted [91] and the importance of characterizing viral persistence in the case of 
HCV and HIV will provide novel and applicable insights on how to intervene using new 
methodologies to boost recognition and signaling for effective viral clearance. 
Specifically, in the case of HCV, multiple single mutant variants has been shown that 
rises from the error-prone RNA polymerase, as well as double mutants [92-96]. 
Characterizing these mutations will provide unique methodologies to create optimal 
chimeric antigen receptor to intervene and induce an efficient signal to generate a 
functional lysis response, thereby eliminating escape mutants stemming from these 
persistent viral infections, like HCV [97]. 
 In regards to future directions of LCMV study, we could extend into 
understanding the gene profile that influences enhanced 2D effective affinity seen for the 
antigen specific T cells from the RP. Based on our indication, these genes should have 
influence in membrane cluster formation, in addition to the subset it is categorized as 
MPEC or SLEC. Squalene injection of CD4+ T cell has shown to induce increased 
membrane cholesterol and diverting towards an inflammatory response and this direction 
has influenced increase T-bet expression [98]. Increased T-bet expression is seen for cells 
in the SLEC lineage and this increased T-bet is linked to an IL-12 cytokine response and 
increased IFN-γ and granzyme B [8, 99], thereby, worth investigating the effects of IL-12 
effect on TCR-pMHC 2D effective binding affinity. Our preliminary data indicates by T-
bet transduction using T-bet DNA fragment sub-cloned into pGC-FU lentiviral vector 
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containing GFP to generate a recombinant lentiviral vector that over-express T-bet 
transcription factor. Additionally, a control pGC-Fu lentiviral vector containing GFP with 
no T-bet DNA fragment was also generated. Following 7dpi, when T cells from both 
compartments exhibited comparable 2D effective affinity, adoptively transferred 
collective P14 T cells from the spleen were sorted and transduced with the lentivirus 
overnight. Followed by 2D micropipette adhesion frequency assay resulted in T-cells 
over-expressing T-bet exhibited 2-times increased binding affinity than control 
transfection (Figure 33a). Following transduction to over-express T-bet resulted in lower 
TCR expression (Figure 33b). Future direction could involve to segregate the two 
compartments from 11dpi samples and potentially might expect in the case if 11dpi RP 
has already increased T-bet, treating the RP T cells with the lentivirus to over-express T- 
bet might not indicate a big difference when compared to untreated RP T cells.  
 Along the line of LCMV study, we focused on acute infection role on anatomic 
compartmentalization of T cells. Following LCMV Armstrong infection, this viral strain 
exhibit distinct tropisms within the RP, which explains an increase of antigen specific T 
cells found in the RP [100, 101].  Whereas LCVM Clone 13 strain, which induces 
chronic infection, prefers the WP for its tropical location and could explain the induction 
leading to disruption of generating a proper immune response, in which case the infection 













Figure 33. T-bet transduction on T cells. (a) Comparison of 11dpi samples 
sorted from their respective compartments and to of spleoncytes from 7dpi with 
T-bet or control transduction. (b) TCR expression between cells transduced with 
T-bet or control. 
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could result in exhausting the adaptive immune response and fail to facilitate viral 
clearance [100, 102]. 
 Overall, this study has initiated using biophysical methodologies to study how 
immune responds upon viral infection and how virus takes advantage of the natural 
phenomenon of the host to use it to it owns advantage for its persistence and possibly 
leading detrimental result of the host, in the case of viral mutations. However, this project 
can be expanded beyond the scope by looking into other infections as the assays used in 
this project provide unique data readouts and experimental setup. One intriguing field is 
in autoimmune disease, human immunodeficiency virus as an example or even 
autoimmune hepatitis, to understand kinetics of immune response leading to the loss of 
differentiating between viral proteins and endogenous proteins of the host. Furthermore, 
understanding the kinetics involved in initiating an effective immune response mediated 
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